{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":64,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":64,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"277401410e68","filters":{"venue":"American Journal of Cardiovascular Drugs"}},"results":[{"id":"W1970093780","doi":"10.2165/00129784-200404050-00002","title":"Interactions Between Grapefruit Juice and Cardiovascular Drugs","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; Felodipine; Medicine; Fluvastatin; Nisoldipine; Repaglinide; Nitrendipine; Verapamil; Oral administration; Cisapride; Pharmacokinetics; Chemistry; Nifedipine; Metformin; Endocrinology; Internal medicine; Simvastatin; Insulin; Calcium","authors":[{"name":"David G. Bailey","is_ca":true},{"name":"George K. Dresser","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08993227723574834,"gpt":0.4283636371771155,"spread":0.3384313599413671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00491992,0.001147805,0.00742558,0.001022551,0.000367897,0.0001103795,0.001176285,0.0004781983,0.0001182746],"category_scores_gemma":[0.0001275087,0.000999247,0.01139343,0.001222493,0.0009946333,0.0002847546,0.0003545262,0.003913647,0.0001019644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002947047,"about_ca_system_score_gemma":0.001042701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000948248,"about_ca_topic_score_gemma":4.630221e-7,"domain_scores_codex":[0.9913803,0.003427236,0.002068872,0.0008635446,0.00130955,0.0009505361],"domain_scores_gemma":[0.9948111,0.0008574713,0.001590544,0.00109303,0.0005414247,0.001106495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002876336,0.00008554853,0.00000995079,0.001871053,0.05992165,0.0002155548,0.0006952396,0.0005993269,0.00000121731,0.0000311062,0.0003063487,0.9362342],"study_design_scores_gemma":[0.001674059,0.0001341462,0.000009428446,0.001832105,0.06750425,0.001465827,0.0003718124,0.000003538419,0.00002885979,0.00009214339,0.9260075,0.0008763079],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005969114,0.9928117,0.0006731673,0.00006865402,0.003197475,0.0007618366,0.0001617297,0.00005169915,0.00167678],"genre_scores_gemma":[0.004264575,0.9914216,0.0006239428,0.00019693,0.003073011,0.00005919479,0.00003768455,0.0002063162,0.0001167944],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9353579,"threshold_uncertainty_score":0.9992458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062044681","doi":"10.2165/00129784-200303060-00004","title":"Cancer of the Heart","year":2003,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Medical physics; Internal medicine; Cardiology","authors":[{"name":"Jennifer M. Sarjeant","is_ca":true},{"name":"Jagdish Butany","is_ca":true},{"name":"Robert J. Cusimano","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0160831803983754,"gpt":0.3086130721081177,"spread":0.2925298917097423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001168368,0.0003330179,0.005938397,0.0001884096,0.00004028362,0.00001117902,0.0002719371,0.00008617502,0.00003983207],"category_scores_gemma":[0.0000767507,0.0001868194,0.01536345,0.0008361536,0.0004259137,0.00003546384,0.00005734315,0.0007548799,0.000005741411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001979904,"about_ca_system_score_gemma":0.001469217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001238682,"about_ca_topic_score_gemma":3.05031e-7,"domain_scores_codex":[0.9967902,0.0006077464,0.0009708588,0.0002080166,0.001168005,0.0002551305],"domain_scores_gemma":[0.9972088,0.00008570167,0.001160934,0.0009834039,0.0003771885,0.0001839819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009026287,0.00003286225,0.00003583189,0.002113572,0.01184895,0.00004223758,0.00006212405,0.00001479773,3.796308e-7,0.00001089015,0.001583953,0.9842454],"study_design_scores_gemma":[0.0003917412,0.0001396247,0.00008619326,0.01027417,0.02125661,0.00382306,0.0001020729,7.403233e-8,0.000007854414,0.000004199805,0.9637527,0.000161688],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000248401,0.9969223,0.00002442239,0.00007141226,0.0009730589,0.0003713899,0.00001886228,0.0000042034,0.001365926],"genre_scores_gemma":[0.0006983067,0.9981244,0.0001775686,0.0001348027,0.0006391026,0.00001078729,0.000001294488,0.0000710606,0.0001426509],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9840837,"threshold_uncertainty_score":0.9944974,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034365627","doi":"10.2165/00129784-200505050-00002","title":"Anticoagulant Use in Patients with Chronic Renal Impairment","year":2005,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Anticoagulant; Anticoagulant therapy; Chronic renal failure; Internal medicine; Cardiology","authors":[{"name":"Anne Grand Maison","is_ca":true},{"name":"Andre F. Charest","is_ca":true},{"name":"William Geerts","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02260685290461545,"gpt":0.2858627153456094,"spread":0.2632558624409939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009661345,0.0006832877,0.007180947,0.0007855516,0.0000487689,0.00006079499,0.0003547852,0.0001694031,0.00003428767],"category_scores_gemma":[0.00005752655,0.0004495661,0.003679707,0.0009563498,0.0002712254,0.0002627166,0.00009354378,0.001204662,0.00003427372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001517729,"about_ca_system_score_gemma":0.001838612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001953514,"about_ca_topic_score_gemma":0.000008912495,"domain_scores_codex":[0.9953987,0.0005503779,0.001465619,0.0004922746,0.001455418,0.0006375805],"domain_scores_gemma":[0.996892,0.0001090775,0.001150437,0.001033849,0.0003576728,0.0004569252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001065771,0.0003626016,0.001353254,0.001105559,0.0123025,0.0003474377,0.00008821171,0.00005321415,2.486501e-7,0.000002193387,0.00004563378,0.9842325],"study_design_scores_gemma":[0.004316669,0.002959947,0.01713539,0.02074667,0.01492182,0.0009480491,0.00003175886,0.000001530051,0.000002213983,4.710345e-7,0.9383851,0.0005504159],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04349438,0.9550815,0.00005720582,0.0000248968,0.0001521623,0.001053995,0.00001499965,0.00001639533,0.000104494],"genre_scores_gemma":[0.03017646,0.9680703,0.0008788949,0.00004410405,0.0006165219,0.00001835875,0.0000371892,0.0001367094,0.00002140115],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9836822,"threshold_uncertainty_score":0.9997956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026737636","doi":"10.2165/00129784-200808020-00001","title":"Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia","year":2008,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Niacin; Simvastatin; Medicine; Dyslipidemia; Tolerability; Internal medicine; Triglyceride; Lovastatin; Pharmacology; Gastroenterology; Urology; Adverse effect; Endocrinology; Cholesterol; Obesity","authors":[{"name":"Richard H. Karas","is_ca":false},{"name":"Moti L. Kashyap","is_ca":false},{"name":"Robert H. Knopp","is_ca":false},{"name":"L Keller","is_ca":true},{"name":"Daiva Bajorunas","is_ca":true},{"name":"Michael H. Davidson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004725128016476281,"gpt":0.2218160939377276,"spread":0.2170909659212513,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001286983,0.0001763511,0.001509395,0.0002821631,0.00003941616,0.000003702378,0.00006833213,0.00004541907,0.000002920161],"category_scores_gemma":[0.0002251624,0.0001342448,0.0005143652,0.0004209189,0.0004605515,0.0001188888,0.00003180794,0.0002720181,1.686265e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007311066,"about_ca_system_score_gemma":0.0002215993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000161593,"about_ca_topic_score_gemma":0.000002042891,"domain_scores_codex":[0.9974421,0.0003483522,0.0007663331,0.0002100955,0.001032157,0.0002009255],"domain_scores_gemma":[0.9981911,0.0001191006,0.0005898796,0.0004116162,0.0004717572,0.0002165313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003383335,0.0004827329,0.5299559,0.0003329862,0.002934714,0.000146603,0.001483101,0.0002062184,0.00003894874,0.00001440884,0.000005556198,0.4610155],"study_design_scores_gemma":[0.01490081,0.002206686,0.9806134,0.0004853462,0.0007297728,0.0003238882,0.0002644113,0.00001536993,0.0002500963,0.000004211291,0.0000832384,0.0001227311],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938412,0.004356967,0.001206628,0.00005983199,0.0000290989,0.0004411815,0.000005221457,0.000004478298,0.00005533283],"genre_scores_gemma":[0.996724,0.002051667,0.001103768,0.00003589312,0.00004720136,0.000002166006,0.000006209199,0.00002480523,0.000004302019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4608928,"threshold_uncertainty_score":0.5474344,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W18416084","doi":"10.2165/00129784-200202050-00005","title":"Prevention of Restenosis with Antioxidants","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Pharmacotherapy; Restenosis; Intensive care medicine; Pharmacology; Internal medicine; Stent","authors":[{"name":"Jean‐Claude Tardif","is_ca":true},{"name":"Jean Gr goire","is_ca":true},{"name":"Philippe L. L Allier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03257317113756302,"gpt":0.3075143393641712,"spread":0.2749411682266082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008728157,0.0004376417,0.005740749,0.000594745,0.00004486913,0.00001578004,0.0002675906,0.0001308827,0.00003517276],"category_scores_gemma":[0.00009013701,0.0002927251,0.005220878,0.0009849633,0.0005488336,0.0001926832,0.00004401227,0.0007122716,0.000009050606],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001123362,"about_ca_system_score_gemma":0.0004332428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002549094,"about_ca_topic_score_gemma":4.233138e-7,"domain_scores_codex":[0.9963693,0.0006607661,0.001084484,0.0003094209,0.001294396,0.0002816458],"domain_scores_gemma":[0.9959949,0.0001500948,0.002404287,0.0006829281,0.0005715227,0.0001963193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009627223,0.0002028122,0.00003958031,0.004851818,0.01558197,0.0002456366,0.0001056045,0.000007984409,0.00000139659,0.000006248118,0.00007244201,0.9787883],"study_design_scores_gemma":[0.001309311,0.00255611,0.0002427176,0.05065188,0.03145034,0.00413301,0.0004288895,9.922323e-7,0.00005919524,0.000003991045,0.9087858,0.000377805],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002131572,0.9944588,0.001721253,0.00001637944,0.00009711355,0.0004574293,0.00001616125,0.00001117431,0.001090146],"genre_scores_gemma":[0.005382733,0.9922914,0.001734048,0.000008272543,0.0003077451,0.000006933991,0.00000864818,0.00007586259,0.0001843397],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9784104,"threshold_uncertainty_score":0.9999525,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087243140","doi":"10.1007/bf03256591","title":"Non-Hemodynamic Effects of Organic Nitrates and the Distinctive Characteristics of Pentaerithrityl Tetranitrate","year":2009,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sinai Health System; University Health Network; Mount Sinai Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Isosorbide dinitrate; Medicine; Isosorbide mononitrate; Angina; Heart failure; Hemodynamics; Intensive care medicine; Cardiology; Pharmacology; Internal medicine","authors":[{"name":"Tommaso Gori","is_ca":true},{"name":"Andreas Daiber","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003379086508718178,"gpt":0.2343642546650775,"spread":0.2309851681563593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001431431,0.0004577991,0.006944551,0.0002378052,0.00005291649,0.00001648094,0.0002338468,0.0001488956,0.0000040567],"category_scores_gemma":[0.0002246414,0.0002589952,0.005096475,0.0005656449,0.00106895,0.00005248173,0.00006704249,0.0008443113,0.000001199393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009200853,"about_ca_system_score_gemma":0.0005017401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002985146,"about_ca_topic_score_gemma":1.98503e-7,"domain_scores_codex":[0.9968808,0.0005468591,0.00124161,0.0002618867,0.0008341864,0.0002347061],"domain_scores_gemma":[0.9963739,0.0005398474,0.001811618,0.000605521,0.0005052264,0.0001638795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001871136,0.00008984492,0.00002854503,0.00968158,0.008669529,0.0001436251,0.0004182892,4.691075e-7,0.0002216605,0.000003987876,0.000006241125,0.9805491],"study_design_scores_gemma":[0.0338537,0.008962866,0.007860648,0.2179204,0.3959953,0.03637297,0.004015245,0.00004562322,0.006620287,0.00009011413,0.2851421,0.00312078],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09070432,0.9078011,0.0002232407,0.00001583085,0.0002056581,0.0007534442,0.00001335999,0.000005208864,0.000277825],"genre_scores_gemma":[0.2080695,0.791451,0.0001176309,0.00001368459,0.000269342,0.000005367815,0.00001299295,0.00004816453,0.00001222809],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9774283,"threshold_uncertainty_score":0.9999862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889103054","doi":"10.1007/s40256-018-0298-8","title":"The Effect of Bromodomain and Extra-Terminal Inhibitor Apabetalone on Attenuated Coronary Atherosclerotic Plaque: Insights from the ASSURE Trial","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Intravascular ultrasound; Medicine; Interquartile range; Internal medicine; Cardiology; Atheroma; Apolipoprotein B; Cholesterol; Vulnerable plaque; Placebo; Rosuvastatin; Population; High-density lipoprotein; Gastroenterology; Pathology","authors":[{"name":"Daisuke Shishikura","is_ca":false},{"name":"Yu Kataoka","is_ca":false},{"name":"Satoshi Honda","is_ca":false},{"name":"Kohei Takata","is_ca":false},{"name":"Susan Kim","is_ca":false},{"name":"Jordan Andrews","is_ca":false},{"name":"Peter J. Psaltis","is_ca":false},{"name":"Michael Sweeney","is_ca":true},{"name":"Ewelina Kulikowski","is_ca":true},{"name":"Jan Johansson","is_ca":true},{"name":"Norman C.W. Wong","is_ca":true},{"name":"Stephen J. Nicholls","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004287510522323123,"gpt":0.2127331452316514,"spread":0.2084456347093283,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009587253,0.000192872,0.0004585487,0.00003345922,0.0001703977,0.00003702825,0.0002996773,0.00007507837,0.000003100585],"category_scores_gemma":[0.0002005111,0.0001026024,0.0005742178,0.0001316076,0.0009060058,0.00001036313,0.00006659725,0.0002092834,0.000003211911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001679414,"about_ca_system_score_gemma":0.00006790413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003921194,"about_ca_topic_score_gemma":0.000003849151,"domain_scores_codex":[0.9977193,0.0009931882,0.0004000497,0.00021382,0.000505591,0.0001680566],"domain_scores_gemma":[0.9986504,0.0002132184,0.0004053738,0.0004914082,0.0001495036,0.00009004137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0665244,0.0002249538,0.002472398,0.00003202276,0.01265173,0.00008425675,0.001291636,0.0001401758,0.3456989,0.0000469971,0.005777475,0.565055],"study_design_scores_gemma":[0.04388982,0.0352414,0.01468977,0.0003390654,0.001471215,0.0003609825,0.0009388289,0.0000632628,0.7948415,0.00008140272,0.1074527,0.0006301225],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941535,0.00456018,0.0002796649,0.000181481,0.0003907578,0.000345343,0.00000981729,0.000003543621,0.00007572638],"genre_scores_gemma":[0.9980146,0.0004520543,0.00007711963,0.00009340438,0.00130053,0.000007865444,0.000009274722,0.00002297266,0.00002223438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5644249,"threshold_uncertainty_score":0.4184006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992908766","doi":"10.2165/10061630-000000000-00000","title":"Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbott (Canada)","funders":"AstraZeneca","keywords":"Dyslipidemia; Medicine; Atorvastatin; Statin; Rosuvastatin; Simvastatin; Internal medicine; Pharmacology; Type 2 Diabetes Mellitus; Fixed-dose combination; Combination therapy; Gastroenterology; Fenofibrate; Adverse effect; Diabetes mellitus; Endocrinology","authors":[{"name":"Peter H. Jones","is_ca":false},{"name":"Kenneth Cusi","is_ca":false},{"name":"Michael H. Davidson","is_ca":false},{"name":"Maureen T. Kelly","is_ca":true},{"name":"Carolyn M. Setze","is_ca":true},{"name":"Kamlesh M. Thakker","is_ca":true},{"name":"Darryl J. Sleep","is_ca":true},{"name":"James C. Stolzenbach","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005073515122734928,"gpt":0.2288428415915501,"spread":0.2237693264688152,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001495709,0.0002914258,0.001811285,0.00023571,0.00006253614,0.00002730979,0.0001065072,0.00007438054,0.000008667318],"category_scores_gemma":[0.0001786842,0.0001799036,0.0002949413,0.0005152606,0.0005081293,0.0001527243,0.00003540812,0.0005165237,6.690672e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005113876,"about_ca_system_score_gemma":0.0004701244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007691649,"about_ca_topic_score_gemma":0.0000121624,"domain_scores_codex":[0.9972807,0.000323193,0.0006674279,0.0003281629,0.001027196,0.0003733659],"domain_scores_gemma":[0.997897,0.0001415427,0.0004643863,0.0006074776,0.0004917487,0.000397839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0294062,0.0005037469,0.1638466,0.0007347428,0.009880019,0.0002168679,0.001985623,0.0004880213,0.0006148771,0.0000101494,0.00002653142,0.7922866],"study_design_scores_gemma":[0.03190617,0.0100609,0.9468952,0.0009766356,0.00210985,0.0002773234,0.0009544776,0.00008678041,0.003653559,0.000006922575,0.002583256,0.0004889457],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953489,0.003564173,0.0002154242,0.0000779179,0.00007627732,0.0006303882,0.00001133914,0.000009242319,0.00006630198],"genre_scores_gemma":[0.9947488,0.0008613818,0.004116411,0.00008533811,0.0001106499,0.000005931625,0.00001084731,0.0000532164,0.000007403381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7917977,"threshold_uncertainty_score":0.7336257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W172350394","doi":"10.2165/11533430-000000000-00000","title":"Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbott (Canada)","funders":"Merck; AstraZeneca","keywords":"Rosuvastatin; Simvastatin; Fenofibrate; Medicine; Rosuvastatin Calcium; Pharmacology; Statin; Combination therapy; Internal medicine","authors":[{"name":"Eli M. Roth","is_ca":false},{"name":"James M. McKenney","is_ca":false},{"name":"Maureen T. Kelly","is_ca":true},{"name":"Carolyn M. Setze","is_ca":true},{"name":"Dawn M. Carlson","is_ca":true},{"name":"Alex Gold","is_ca":false},{"name":"James C. Stolzenbach","is_ca":true},{"name":"Laura Williams","is_ca":true},{"name":"Peter H. Jones","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005283008122858314,"gpt":0.2265046990454886,"spread":0.2212216909226302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001334336,0.0002241372,0.001146379,0.0002431223,0.00005465486,0.00002379371,0.00007041093,0.00006622323,0.000002808126],"category_scores_gemma":[0.0000962099,0.0001643843,0.0002491237,0.0003218289,0.0004021165,0.0001705045,0.00002569035,0.0004437708,1.634184e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004194969,"about_ca_system_score_gemma":0.0001348095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001640315,"about_ca_topic_score_gemma":0.000005437517,"domain_scores_codex":[0.9979814,0.0002484721,0.0005281509,0.0002668029,0.0007465442,0.0002286368],"domain_scores_gemma":[0.9986085,0.0001596283,0.0003435706,0.0003744838,0.0002840945,0.0002297452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01002946,0.0001554837,0.08332594,0.00005863914,0.001678216,0.00001812215,0.001228483,0.00004477249,0.0008888923,0.00001395737,0.000002514953,0.9025555],"study_design_scores_gemma":[0.05127997,0.004455348,0.939972,0.0001638611,0.0003787415,0.0001871438,0.0005590365,0.0000272733,0.0008114293,0.00001055959,0.001950291,0.0002043421],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945291,0.004377679,0.0002836161,0.0001465555,0.00007225133,0.0005386596,0.000006194209,0.000007237911,0.00003866703],"genre_scores_gemma":[0.9925577,0.004170837,0.003059231,0.00008968526,0.00007161802,0.000005417681,0.000004878945,0.00003885421,0.000001783068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9023512,"threshold_uncertainty_score":0.6703396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2183532679","doi":"10.2165/00129784-200202030-00003","title":"Cardiovascular Risk in Patients with Early Renal Insufficiency","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Population; Risk factor; Coronary artery disease; Blood pressure; Creatinine; Incidence (geometry); Renal function; Kidney disease; Stroke (engine); Cardiology","authors":[{"name":"Johannes F.E. Mann","is_ca":false},{"name":"Hertzel C. Gerstein","is_ca":true},{"name":"Janice Pogue","is_ca":true},{"name":"Eva Lonn","is_ca":true},{"name":"Salim Yusuf","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01392199875403943,"gpt":0.236022855591769,"spread":0.2221008568377296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00171168,0.0007363592,0.01038783,0.0009495162,0.0001050117,0.00003925365,0.0004014464,0.000197148,0.00001500622],"category_scores_gemma":[0.0001415032,0.0004671513,0.008780537,0.001511959,0.0004344375,0.0001494694,0.0001150757,0.001739487,0.00003162092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001154548,"about_ca_system_score_gemma":0.0003540005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001968537,"about_ca_topic_score_gemma":7.634045e-7,"domain_scores_codex":[0.993765,0.0009798488,0.001443659,0.0006047553,0.002631636,0.0005750944],"domain_scores_gemma":[0.9959777,0.0001424009,0.001236092,0.00141091,0.00090021,0.0003327105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008690303,0.0003722609,0.0008421296,0.0009161325,0.0604371,0.000635303,0.0002880643,0.00005628729,2.8393e-9,6.424447e-7,0.0004069204,0.9359583],"study_design_scores_gemma":[0.002996272,0.001924186,0.002568526,0.00808574,0.08324997,0.0005369629,0.0001035125,4.845235e-7,1.64055e-7,7.690097e-7,0.9000692,0.0004642537],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002428597,0.9957642,0.0001004712,0.0000118318,0.000225687,0.0007360795,0.00002201714,0.00002065933,0.000690463],"genre_scores_gemma":[0.004426809,0.9941477,0.000661783,0.00006625015,0.0005021108,0.00002017679,0.000008330698,0.0001276385,0.00003918767],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.935494,"threshold_uncertainty_score":0.999778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896677774","doi":"10.1007/s40256-018-0305-0","title":"Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Canadian Heart Research Centre; Southlake Regional Health Center; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Morphine; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Internal medicine; Anesthesia","authors":[{"name":"Frédéric Lapostolle","is_ca":false},{"name":"Arnoud W.J. van ’t Hof","is_ca":false},{"name":"Christian W. Hamm","is_ca":false},{"name":"Olivier Stibbe","is_ca":false},{"name":"Patrick Ecollan","is_ca":false},{"name":"Jean‐Philippe Collet","is_ca":false},{"name":"Johanne Silvain","is_ca":false},{"name":"Jens Flensted Lassen","is_ca":false},{"name":"Wim M.J.M. Heutz","is_ca":false},{"name":"Leonardo Bolognese","is_ca":true},{"name":"Warren J. Cantor","is_ca":true},{"name":"Ángel Cequier","is_ca":false},{"name":"Mohamed Chettibi","is_ca":true},{"name":"Shaun G. Goodman","is_ca":true},{"name":"Christopher Hammett","is_ca":false},{"name":"Kurt Huber","is_ca":false},{"name":"Magnus Janzon","is_ca":false},{"name":"Béla Merkely","is_ca":false},{"name":"Robert F. Storey","is_ca":false},{"name":"Jur ten Berg","is_ca":false},{"name":"Uwe Zeymer","is_ca":false},{"name":"Muriel Licour","is_ca":false},{"name":"Anne Tsatsaris","is_ca":false},{"name":"Gilles Montalescot","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006196942118179152,"gpt":0.2353668853884501,"spread":0.2291699432702709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001347439,0.0002407521,0.001035515,0.000523757,0.00005216591,0.0000319424,0.0001004936,0.00007123515,0.00005954772],"category_scores_gemma":[0.00007876936,0.0002169789,0.001124675,0.000513444,0.0003250688,0.0003315556,0.00005279316,0.0004065609,0.000008831592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003624035,"about_ca_system_score_gemma":0.0001108112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002701411,"about_ca_topic_score_gemma":0.00001017437,"domain_scores_codex":[0.9975107,0.0003663007,0.0007568619,0.0003060989,0.0007897743,0.0002702049],"domain_scores_gemma":[0.9988475,0.00006235169,0.0002959174,0.0003403157,0.0002907008,0.0001631871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005395536,0.0004515283,0.08548024,0.0001257789,0.006367888,0.001872029,0.001156191,0.0009165386,0.001618706,0.00001272267,0.0001344714,0.8964683],"study_design_scores_gemma":[0.01270308,0.00450344,0.9153645,0.001239475,0.002672073,0.03440916,0.003804319,0.0006769539,0.0003238805,0.00009967171,0.02362181,0.0005816622],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903541,0.006079037,0.002312707,0.0003666375,0.0003481914,0.0003439009,0.000003727739,0.00001844312,0.0001732597],"genre_scores_gemma":[0.9935942,0.004681882,0.0006348151,0.0003057101,0.0006933249,0.000008117384,0.0000326793,0.00003393086,0.00001528634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8958867,"threshold_uncertainty_score":0.8848143,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W79675979","doi":"10.2165/00129784-200606050-00006","title":"The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study)","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo","keywords":"Olmesartan; Medicine; Internal medicine; Angiotensin II; Cardiology; Angiotensin II receptor type 1; Vascular resistance; Blockade; Atenolol; Essential hypertension; Urology; Blood pressure; Endocrinology; Receptor","authors":[{"name":"Ronald D. Smith","is_ca":false},{"name":"Hiroshi Yokoyama","is_ca":false},{"name":"David B. Averill","is_ca":false},{"name":"Lori Cooke","is_ca":false},{"name":"K. Bridget Brosnihan","is_ca":false},{"name":"Ernesto L. Schiffrin","is_ca":true},{"name":"Carlos M. Ferrario","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004372642364146629,"gpt":0.2060415327259775,"spread":0.2016688903618309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337288,0.0002316091,0.001279577,0.0001059459,0.0004445658,0.00001845316,0.0002061391,0.00003190375,3.87193e-7],"category_scores_gemma":[0.0001500282,0.0001093125,0.0007971337,0.0004841112,0.0004946738,0.00004813203,0.00005384661,0.0004780684,8.622278e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002890229,"about_ca_system_score_gemma":0.0001242067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001598302,"about_ca_topic_score_gemma":0.00001713207,"domain_scores_codex":[0.9972354,0.0004596002,0.0004951584,0.0002300772,0.001310112,0.0002696359],"domain_scores_gemma":[0.9973241,0.000450878,0.00049882,0.0007197547,0.0009322455,0.0000741721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0327029,0.006474022,0.008354765,0.0007871178,0.27174,0.005459848,0.04890382,0.03051299,0.02363991,0.0004058611,0.03911194,0.5319068],"study_design_scores_gemma":[0.03858926,0.0335329,0.1686708,0.007180746,0.09725036,0.00366403,0.06083308,0.0002563452,0.1089552,0.000783931,0.4782857,0.001997628],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9499236,0.04370968,0.0005739747,0.003937797,0.0001340491,0.001116542,0.000001125885,0.00001850935,0.000584696],"genre_scores_gemma":[0.9981707,0.0004166828,0.0005390295,0.0002915189,0.0004158119,0.00001915732,2.137558e-7,0.00003485995,0.000112025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5299093,"threshold_uncertainty_score":0.4457636,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W206416980","doi":"10.2165/00129784-200606030-00003","title":"Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Sirolimus; Restenosis; Stent; Angioplasty; Coronary arteries; Internal medicine; Cost effectiveness; Relative risk; Surgery; Artery; Confidence interval","authors":[{"name":"St phane Rinfret","is_ca":true},{"name":"David J. Cohen","is_ca":true},{"name":"Amir Abbas Tahami Monfared","is_ca":true},{"name":"Jacques LeLorier","is_ca":false},{"name":"Jean Mireault","is_ca":false},{"name":"Érick Schampaert","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005090075173915663,"gpt":0.2138032925138572,"spread":0.2087132173399415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008668398,0.000105356,0.0006549748,0.0001289568,0.00002239284,0.000004079895,0.0001250749,0.00001720981,0.000004027688],"category_scores_gemma":[0.0002286916,0.00007514375,0.000638783,0.0004322038,0.00008007222,0.00003823826,0.00004088257,0.0002730875,2.967429e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000630389,"about_ca_system_score_gemma":0.0005321025,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8012185,"about_ca_topic_score_gemma":0.1156899,"domain_scores_codex":[0.9980425,0.0005149315,0.0005560786,0.0001048922,0.0006012791,0.0001803024],"domain_scores_gemma":[0.9987583,0.0003194746,0.0003762505,0.0002681624,0.000223481,0.00005436657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001364191,0.0001689068,0.8989077,0.00004710845,0.0003272262,0.00007652662,0.00005321887,0.02772956,0.000006267519,0.000005802071,0.00001906933,0.07252216],"study_design_scores_gemma":[0.00338523,0.00025773,0.9937531,0.0007112178,0.000333385,0.0000402909,0.0005966861,0.00005958619,0.0002832747,0.00002185426,0.0004877242,0.00006986586],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978311,0.001342431,0.0001623173,0.00003768471,0.0002375257,0.0002601613,0.0000139711,0.000001239953,0.0001135917],"genre_scores_gemma":[0.9996461,0.0001788778,0.00007817168,0.00002299439,0.00005121949,0.000004630598,0.000002856943,0.00001233849,0.00000277158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6855286,"threshold_uncertainty_score":0.9004464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2602040050","doi":"10.1007/s40256-017-0227-2","title":"The 100 Most Influential Papers in the Field of Thrombolytic Therapy: A Bibliometric Analysis","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Scopus; Medicine; Citation; Bibliometrics; MEDLINE; Library science; Family medicine; Political science; Computer science; Law","authors":[{"name":"Tariq Jamal Siddiqi","is_ca":false},{"name":"Muhammad Usman","is_ca":false},{"name":"Muhammad Shahzeb Khan","is_ca":false},{"name":"Kaneez Fatima","is_ca":false},{"name":"Alexander Norbash","is_ca":false},{"name":"Adnan I. Qureshi","is_ca":false},{"name":"Abdur Rahman Khan","is_ca":false},{"name":"Faisal Khosa","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0279136496236731,"gpt":0.3564253405306674,"spread":0.3285116909069943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.005227095,0.0005319463,0.006193895,0.01663748,0.0002433429,0.0001555437,0.001493464,0.0001816765,0.00002852378],"category_scores_gemma":[0.0006774936,0.0002601116,0.02028844,0.04886294,0.0007419586,0.0001117972,0.00008041804,0.0009970005,0.000004252891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008354431,"about_ca_system_score_gemma":0.0008156823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002174063,"about_ca_topic_score_gemma":0.00000304368,"domain_scores_codex":[0.9937,0.00165101,0.001497463,0.0003609327,0.002337491,0.000453064],"domain_scores_gemma":[0.9936426,0.001381365,0.001976432,0.002445712,0.0003817714,0.0001720846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001353956,0.00008840972,0.0001248237,0.0004671055,0.1020503,0.0002400269,0.0001812584,0.00005467488,1.58903e-7,0.000004104852,0.00009598829,0.8965577],"study_design_scores_gemma":[0.001226182,0.0005536125,0.00190128,0.001771718,0.05622246,0.0005627109,0.0005331707,0.000002005913,0.000002095817,0.000004932864,0.9369663,0.0002535213],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002644264,0.9953508,0.00008893936,0.0001001819,0.0001940009,0.0006541522,0.00001153085,0.000007214004,0.0009489077],"genre_scores_gemma":[0.03305528,0.9661543,0.00002908014,0.0002063715,0.0004408936,0.00002765252,0.00001078791,0.00005468482,0.0000210002],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9368703,"threshold_uncertainty_score":0.9999851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035728262","doi":"10.2165/11587000-000000000-00000","title":"Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study","year":2011,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Dr. Georges-L.-Dumont University Hospital Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Perindopril; Tolerability; Internal medicine; Indapamide; Adverse effect; Population; Observational study; Blood pressure","authors":[{"name":"George Tsoukas","is_ca":true},{"name":"Sanjiv Anand","is_ca":true},{"name":"Kwang Ik Yang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05991055248742008,"gpt":0.2888497181520132,"spread":0.2289391656645931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981421,0.0002100043,0.001844032,0.000223374,0.00005875446,0.00001086628,0.0001223181,0.00004483262,0.00001566716],"category_scores_gemma":[0.0005276052,0.0001612863,0.0005508683,0.0002927946,0.0002119444,0.0001675352,0.00007945377,0.0003635286,0.000001226193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002581712,"about_ca_system_score_gemma":0.0002417336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005391725,"about_ca_topic_score_gemma":0.0000111236,"domain_scores_codex":[0.9971968,0.0005126654,0.0007908581,0.0002884327,0.0009691888,0.0002420644],"domain_scores_gemma":[0.9973077,0.0002753975,0.0004908723,0.0004850913,0.001288246,0.00015268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01019707,0.01437014,0.8323274,0.0002214346,0.03710456,0.003760907,0.02878646,0.0006764762,0.001195856,0.00004877784,0.000393362,0.07091755],"study_design_scores_gemma":[0.01201617,0.003436083,0.9551358,0.0001294951,0.006048326,0.0005532851,0.01600382,0.00004788762,0.0005564905,0.000008820183,0.005849841,0.0002139999],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838509,0.01468079,0.000102156,0.0004797399,0.0001053935,0.0004528942,0.000004392787,0.000009416944,0.0003143301],"genre_scores_gemma":[0.9947282,0.0006166213,0.003408853,0.001071871,0.0001307068,0.000007981632,0.000001146673,0.00002380299,0.00001080098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1228084,"threshold_uncertainty_score":0.6577065,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2618833385","doi":"10.1007/s40256-017-0229-0","title":"Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Current (fluid); Pharmacotherapy; Extracorporeal; MEDLINE; Medical physics; Internal medicine; Engineering","authors":[{"name":"Gail M. Annich","is_ca":true},{"name":"Oshri Zaulan","is_ca":true},{"name":"Megan J. Neufeld","is_ca":false},{"name":"D. Wagner","is_ca":false},{"name":"Melissa M. Reynolds","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04069440286404368,"gpt":0.3171915031520488,"spread":0.2764971002880051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001166806,0.000578847,0.004043086,0.0004505378,0.00009200886,0.0002106184,0.0006281086,0.0002005737,0.00003286738],"category_scores_gemma":[0.00002807365,0.0004554392,0.002379729,0.0004188145,0.0002835549,0.0004889441,0.00006458031,0.001626108,0.000008206753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000215292,"about_ca_system_score_gemma":0.0003452043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001485213,"about_ca_topic_score_gemma":0.000001947944,"domain_scores_codex":[0.996912,0.0004185989,0.001191179,0.0003775051,0.0006847729,0.0004159504],"domain_scores_gemma":[0.9981564,0.0001164993,0.0007160719,0.0005833823,0.0001174221,0.0003101861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00000144448,0.00002607773,0.000004454871,0.002113036,0.003101568,0.0002102725,0.0000955651,0.00009779828,2.656961e-7,0.0000338692,0.00002531423,0.9942904],"study_design_scores_gemma":[0.0002502764,0.00009238,0.00009820715,0.001787891,0.003034151,0.0007908916,0.000318758,0.00001688781,4.692897e-7,0.00005901169,0.9930948,0.0004562552],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004406552,0.9964329,0.0002408873,0.000005513814,0.001834782,0.0003466992,0.0000213516,0.0000568545,0.0006203546],"genre_scores_gemma":[0.009278785,0.9888318,0.00009485075,0.000003344742,0.001665035,0.0000340547,0.000007658902,0.0000831799,0.000001332614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9938341,"threshold_uncertainty_score":0.9997897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079420595","doi":"10.2165/00129784-200303030-00006","title":"New Anticoagulants","year":2003,"lang":"fr","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Argatroban; Medicine; Discovery and development of direct thrombin inhibitors; Fondaparinux; Tissue factor; Hirudin; Factor IXa; Ximelagatran; Dabigatran; Prothrombinase; Thrombin; Direct thrombin inhibitor; Lepirudin; Coagulation; Pharmacology; Rivaroxaban; Thrombomodulin; Tissue factor pathway inhibitor; Anticoagulant; Antithrombin; Factor X; Warfarin; Heparin; Thrombosis; Immunology; Internal medicine; Atrial fibrillation; Platelet; Venous thromboembolism","authors":[{"name":"Jeffrey I. Weitz","is_ca":true},{"name":"Mark Crowther","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02632032287731402,"gpt":0.2952242072185761,"spread":0.2689038843412621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003273802,0.000982083,0.009300003,0.0007179869,0.0001246654,0.00009598755,0.0006673447,0.0003540753,0.001102334],"category_scores_gemma":[0.0002382988,0.0008265936,0.01103567,0.001576323,0.000377729,0.0002195873,0.00008858182,0.001517746,0.0008349843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004623114,"about_ca_system_score_gemma":0.003226497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001163349,"about_ca_topic_score_gemma":3.743974e-7,"domain_scores_codex":[0.9916408,0.001870982,0.002380619,0.0006033286,0.002546586,0.0009576617],"domain_scores_gemma":[0.9936395,0.0002519818,0.002426286,0.001445532,0.0007263911,0.00151037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002802681,0.0001393481,0.00002062449,0.001849458,0.03273434,0.0005297978,0.0002401242,0.00009896088,0.000005739942,0.000629679,0.00156403,0.9621599],"study_design_scores_gemma":[0.002219811,0.001073546,0.00006230245,0.01618159,0.04527707,0.008088482,0.0005925497,0.000007743096,0.0000666776,0.0001044217,0.9256442,0.0006816195],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001461226,0.9584551,0.03150915,0.0001807259,0.005672597,0.0005775481,0.00001101836,0.00002241791,0.003425327],"genre_scores_gemma":[0.001994568,0.9796414,0.01227693,0.000422556,0.003963347,0.000004362908,0.0000130663,0.000207664,0.00147605],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9614782,"threshold_uncertainty_score":0.999943,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W124523853","doi":"10.2165/00129784-200101040-00003","title":"Patient Self-Monitoring of Oral Anticoagulant Therapy","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Warfarin; Atrial fibrillation; Intensive care medicine; Anticoagulant; Pharmacotherapy; Self-monitoring; Dosing; Anticoagulant therapy; Surgery; Internal medicine","authors":[{"name":"James D. Douketis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0616797592665561,"gpt":0.3513950330364203,"spread":0.2897152737698642,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009177418,0.0003699517,0.004961701,0.000513172,0.0000357123,0.00002008391,0.0001878508,0.00008629143,0.00001626299],"category_scores_gemma":[0.00005426587,0.0002510249,0.00681413,0.0008202448,0.0001054285,0.000082516,0.00005240693,0.0003380487,0.000008349823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001370287,"about_ca_system_score_gemma":0.0002759547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002495428,"about_ca_topic_score_gemma":1.705823e-8,"domain_scores_codex":[0.9966437,0.0003772648,0.001317076,0.0002132456,0.001194821,0.0002539483],"domain_scores_gemma":[0.9971702,0.0001200203,0.001650378,0.0005621637,0.0003318249,0.0001654044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004549645,0.00001860599,0.001082757,0.001072686,0.01648051,0.0001402373,0.0001637607,0.00002698733,2.802384e-7,0.000003957016,0.00004764756,0.9809171],"study_design_scores_gemma":[0.0009050195,0.0006542425,0.0002478448,0.004121521,0.009841365,0.000505091,0.0003215352,8.168493e-7,0.000008147974,0.000001921778,0.9831797,0.0002127225],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002203469,0.9960784,0.0001764277,0.00004139663,0.0006504683,0.0005050569,0.000002220876,0.00002100611,0.0003215294],"genre_scores_gemma":[0.001812975,0.9940349,0.002655414,0.00001382957,0.001379458,0.000001502869,0.000004939658,0.00006495736,0.00003200914],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9831321,"threshold_uncertainty_score":0.9999942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997002994","doi":"10.2165/00129784-200505060-00002","title":"ACE Inhibitors in Heart Failure","year":2005,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Lisinopril; ACE inhibitor; Internal medicine; Heart failure; Cardiology; Hazard ratio; Valsartan; Angiotensin-converting enzyme; Ramipril; Myocardial infarction; Placebo; Blood pressure; Confidence interval","authors":[{"name":"Catherine Demers","is_ca":true},{"name":"Anita Mody","is_ca":true},{"name":"Koon Teo","is_ca":true},{"name":"Robert S. McKelvie","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01400973644410922,"gpt":0.2939727673296045,"spread":0.2799630308854952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001406628,0.0005155447,0.005381964,0.0009074339,0.00003119675,0.0000308317,0.000211017,0.0001460047,0.0000413015],"category_scores_gemma":[0.00006091397,0.0003722737,0.006092617,0.0009784397,0.0001617292,0.0001244285,0.00007519846,0.0008940886,0.0001061985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005265094,"about_ca_system_score_gemma":0.0005715779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004911546,"about_ca_topic_score_gemma":0.000003814003,"domain_scores_codex":[0.9964776,0.0004693219,0.001191793,0.0003505285,0.00107032,0.0004404135],"domain_scores_gemma":[0.9981638,0.00009205541,0.0005563921,0.0007189943,0.0001434367,0.0003253817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001460395,0.00009781344,0.00001711917,0.001122541,0.005662357,0.0004690902,0.0001150054,0.00001834627,5.381304e-8,0.000003471742,0.01567785,0.9768018],"study_design_scores_gemma":[0.001001271,0.0003816957,0.000008113523,0.009804002,0.00848888,0.001623168,0.0003144788,3.596329e-7,8.385107e-7,0.000001018545,0.9780995,0.0002766538],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004705513,0.9964649,0.00004258954,0.002102934,0.000214038,0.0007473639,0.000002576006,0.00002038176,0.0003581287],"genre_scores_gemma":[0.0001734555,0.9898842,0.008141468,0.0001371085,0.001323677,0.00002630322,0.00001135959,0.00008869843,0.0002137464],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9765251,"threshold_uncertainty_score":0.9998729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W161538956","doi":"10.2165/00129784-200707040-00005","title":"Impact of Weight-Loss Medications on the Cardiovascular System","year":2007,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Weight loss; Overweight; Obesity; Risk factor; Pharmacotherapy; Intensive care medicine; Diabetes mellitus; Adverse effect; Type 2 diabetes; Internal medicine; Endocrinology","authors":[{"name":"Benoît Drolet","is_ca":true},{"name":"Chantale Simard","is_ca":true},{"name":"Paul Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02760185004588557,"gpt":0.3503467495150516,"spread":0.322744899469166,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004493219,0.0006179635,0.006799806,0.0006597853,0.0001321683,0.000009783706,0.0006200114,0.0002347805,0.00004008271],"category_scores_gemma":[0.000112442,0.0003193935,0.02444742,0.001044055,0.0007379059,0.00005335932,0.00006582084,0.001262643,0.00005404432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001103412,"about_ca_system_score_gemma":0.001614814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009870745,"about_ca_topic_score_gemma":1.121677e-7,"domain_scores_codex":[0.994347,0.001446621,0.001439949,0.0003724409,0.001936498,0.0004575388],"domain_scores_gemma":[0.9951121,0.0007249314,0.001465066,0.001677139,0.0005925656,0.0004281859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007625767,0.0002181234,0.00005046292,0.002379392,0.1939865,0.0009601333,0.0001452349,0.0000990526,1.552674e-7,0.00005368533,0.0004856832,0.8015453],"study_design_scores_gemma":[0.001230314,0.001077234,0.00028868,0.009440938,0.09531444,0.007329195,0.0001592636,0.000001459265,0.0000106577,0.000002194894,0.8848854,0.0002601858],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001714569,0.9949905,0.0005240531,0.00006518878,0.0004155379,0.0008684548,0.00003718353,0.00002287199,0.001361627],"genre_scores_gemma":[0.02544917,0.973237,0.0001477252,0.00004574909,0.0009608173,0.0000353594,0.00001763713,0.00007872695,0.00002777212],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8843998,"threshold_uncertainty_score":0.9999258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2977710227","doi":"10.1007/s40256-019-00373-1","title":"Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries","year":2019,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Mace; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Myocardial infarction; Acute coronary syndrome; Cardiology; Clinical endpoint; Randomized controlled trial","authors":[{"name":"Mattia Peyracchia","is_ca":false},{"name":"Andrea Saglietto","is_ca":false},{"name":"Carloalberto Biolè","is_ca":false},{"name":"Sergio Raposeiras‐Roubín","is_ca":false},{"name":"Emad Abu‐Assi","is_ca":false},{"name":"Tim Kinnaird","is_ca":false},{"name":"Albert Ariza‐Solé","is_ca":false},{"name":"Christoph Liebetrau","is_ca":false},{"name":"Sergio Manzano‐Fernández","is_ca":false},{"name":"Giacomo Boccuzzi","is_ca":false},{"name":"Josè P.S. Henriques","is_ca":false},{"name":"Stephen B. Wilton","is_ca":true},{"name":"Lazar Velicki","is_ca":false},{"name":"Ioanna Xanthopoulou","is_ca":false},{"name":"Luís Cláudio Lemos Correia","is_ca":false},{"name":"Andrea Rognoni","is_ca":false},{"name":"Fabrizio Ugo","is_ca":false},{"name":"Iván J. Núñez‐Gil","is_ca":false},{"name":"Andrea Montabone","is_ca":false},{"name":"Salma Taha","is_ca":false},{"name":"Toshiharu Fujii","is_ca":false},{"name":"Alessandro Durante","is_ca":false},{"name":"Sebastiano Gili","is_ca":false},{"name":"Giulia Magnani","is_ca":false},{"name":"Michele Autelli","is_ca":false},{"name":"Alberto Grosso","is_ca":false},{"name":"Tetsuma Kawaji","is_ca":false},{"name":"Pedro Flores Blanco","is_ca":false},{"name":"Alberto Garay","is_ca":false},{"name":"Giorgio Quadri","is_ca":false},{"name":"Berenice Caneiro Queija","is_ca":false},{"name":"Zenon Huczek","is_ca":false},{"name":"Rafael Cobas Paz","is_ca":false},{"name":"José Ramón González‐Juanatey","is_ca":false},{"name":"M Cespon Fernandez","is_ca":false},{"name":"Shaoping Nie","is_ca":false},{"name":"Maurizio D’Amico","is_ca":false},{"name":"Isabel Muñoz Pousa","is_ca":false},{"name":"Masa‐aki Kawashiri","is_ca":false},{"name":"Diego Gallo","is_ca":false},{"name":"Umberto Morbiducci","is_ca":false},{"name":"Alberto Domínguez‐Rodríguez","is_ca":false},{"name":"Ángel López‐Cuenca","is_ca":false},{"name":"Ángel Cequier","is_ca":false},{"name":"Dimitrios Alexopoulos","is_ca":false},{"name":"Andrés Íñiguez","is_ca":false},{"name":"Walter Grosso Marra","is_ca":false},{"name":"Tullio Usmiani","is_ca":false},{"name":"Mauro Rinaldi","is_ca":false},{"name":"Fabrizio D’Ascenzo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006303911963001988,"gpt":0.1991977726743948,"spread":0.1928938607113928,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007044666,0.0001958017,0.001711579,0.0002573498,0.00004011419,0.00001238566,0.00009997719,0.00004957013,0.000002625794],"category_scores_gemma":[0.00009865728,0.0001145106,0.0006656222,0.001031397,0.0008329991,0.0001000177,0.00006254207,0.000202361,1.126047e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003007059,"about_ca_system_score_gemma":0.0001207334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001350103,"about_ca_topic_score_gemma":0.000005017202,"domain_scores_codex":[0.9980584,0.0003177558,0.0005025968,0.0002473734,0.0007055082,0.0001684167],"domain_scores_gemma":[0.9983846,0.0001022714,0.0005053226,0.0005150171,0.0003680154,0.0001247634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003887075,0.0001210223,0.9004813,0.0001306656,0.02353166,0.00003088604,0.0006504423,0.0003133761,0.00007123364,0.000008403274,0.000003716154,0.07077026],"study_design_scores_gemma":[0.008203124,0.001105785,0.975475,0.0005633748,0.01285746,0.0001910484,0.0005188552,0.00002571805,0.0004182959,0.000002218459,0.000501769,0.0001373677],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897043,0.009591508,0.00004897291,0.00006537901,0.00001575811,0.0004907462,0.00001215706,0.000003892828,0.0000672932],"genre_scores_gemma":[0.9944289,0.005397351,0.00008812074,0.00003299339,0.00001568833,0.000001598303,0.000005057016,0.00001740033,0.00001294579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07499372,"threshold_uncertainty_score":0.4669608,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W940111687","doi":"10.2165/00129784-200404040-00001","title":"Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Heart failure; Carnitine; Beta oxidation; Medicine; Fatty acid metabolism; Diabetic cardiomyopathy; Internal medicine; Diabetes mellitus; Fatty acid; Heart disease; Metabolism; Cardiomyopathy; Endocrinology; Pharmacology; Cardiology; Biochemistry; Chemistry","authors":[{"name":"S.A. Mengi","is_ca":true},{"name":"Naranjan S. Dhalla","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0181833940673167,"gpt":0.2860817668543604,"spread":0.2678983727870436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0008892329,0.0006894496,0.007195177,0.0004365144,0.0001059264,0.00002891371,0.000269079,0.0001952688,0.00004514374],"category_scores_gemma":[0.00009555943,0.0003724149,0.02948349,0.0007696774,0.0003465536,0.00005558304,0.00001372237,0.0004953474,0.000008382067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005186779,"about_ca_system_score_gemma":0.002755398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003659545,"about_ca_topic_score_gemma":0.000002328504,"domain_scores_codex":[0.9961955,0.0003684182,0.001374941,0.0003943273,0.00124343,0.0004233843],"domain_scores_gemma":[0.9966647,0.0004366499,0.0007485276,0.001172601,0.0005332598,0.000444257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000137394,0.0001500927,0.00001544793,0.002321532,0.05118992,0.00005553656,0.0003520713,0.0004335903,5.69738e-7,0.000004951857,0.0009068528,0.944432],"study_design_scores_gemma":[0.003501086,0.002964238,0.00001402082,0.004541931,0.05105657,0.003253482,0.0005568931,7.29e-7,0.00003185537,0.0000049922,0.9337709,0.0003032982],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006276994,0.9863145,0.01071708,0.0003244394,0.0007227566,0.001734281,0.00007391945,0.00002136647,0.00002882954],"genre_scores_gemma":[0.0003034776,0.9934726,0.003616506,0.00003936027,0.002186327,0.00005455826,0.00005492246,0.0001425137,0.000129781],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9441288,"threshold_uncertainty_score":0.9998728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037319161","doi":"10.2165/00129784-200404050-00005","title":"Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Augmentium Pharma Consulting (Canada); Health Sciences Centre; Toronto East General Hospital; Jewish General Hospital; Royal Jubilee Hospital; Bausch Health (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Fondaparinux; Medicine; Orthopedic surgery; Low molecular weight heparin; Emergency medicine; Surgery; Intensive care medicine; Venous thromboembolism; Heparin; Thrombosis","authors":[{"name":"George Dranitsaris","is_ca":true},{"name":"Susan R. Kahn","is_ca":true},{"name":"Carmine Stumpo","is_ca":true},{"name":"Thomas W. Paton","is_ca":true},{"name":"Josée Martineau","is_ca":true},{"name":"Reginald E. Smith","is_ca":true},{"name":"Jeffrey S. Ginsberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0365783578006559,"gpt":0.3374377838595827,"spread":0.3008594260589268,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002779084,0.0004229925,0.008900421,0.001661244,0.00004071397,0.000007639165,0.0003471804,0.0001032522,0.00002993376],"category_scores_gemma":[0.0001828836,0.0003023622,0.0120482,0.001660582,0.0002033597,0.0001064756,0.00009944978,0.0003588107,0.000001975465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004512572,"about_ca_system_score_gemma":0.0009745424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004142898,"about_ca_topic_score_gemma":0.00001363735,"domain_scores_codex":[0.9956284,0.000440385,0.002373775,0.0003530593,0.0008475158,0.0003568788],"domain_scores_gemma":[0.9947498,0.0006653311,0.00330769,0.0007657746,0.000376865,0.0001345366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001528426,0.0007326059,0.0005100307,0.004783124,0.09356566,0.000007662848,0.0002102727,0.00189324,8.282183e-8,0.00001441336,0.00007510864,0.898055],"study_design_scores_gemma":[0.007362396,0.00172429,0.0263175,0.01629777,0.4432939,0.0000293992,0.000537681,0.00003195443,0.000008030615,0.00002153048,0.5037623,0.0006132017],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04648786,0.9506741,0.0003793846,0.00001605232,0.0006631546,0.00166697,0.00003500289,0.000005009648,0.00007242477],"genre_scores_gemma":[0.1106761,0.8888063,0.0001211387,0.00001599522,0.0001470983,0.00009178535,0.00007549206,0.00005946199,0.000006649535],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8974417,"threshold_uncertainty_score":0.9999428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385442526","doi":"10.1007/s40256-023-00599-0","title":"Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy","year":2023,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Air Canada","funders":"","keywords":"Medicine; Pharmacotherapy; Hypertrophic cardiomyopathy; Internal medicine; Cardiology; Obstructive cardiomyopathy; Cardiomyopathy; Intensive care medicine; Heart failure","authors":[{"name":"Sneha Annie Sebastian","is_ca":true},{"name":"Inderbir Padda","is_ca":false},{"name":"Eric J. Lehr","is_ca":false},{"name":"Gurpreet Johal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03725592064992825,"gpt":0.3186651068658384,"spread":0.2814091862159102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002217866,0.001003822,0.01246324,0.0008379439,0.0001960544,0.00006572952,0.0004894749,0.0002522404,0.000003948606],"category_scores_gemma":[0.0004139415,0.0007181771,0.02199163,0.00160345,0.0006823037,0.0001366505,0.0001333155,0.0008907357,0.00003647415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004692063,"about_ca_system_score_gemma":0.001085967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003670956,"about_ca_topic_score_gemma":1.436433e-7,"domain_scores_codex":[0.9944233,0.0006887352,0.001854966,0.0007151276,0.001567821,0.0007500005],"domain_scores_gemma":[0.9947119,0.0008477929,0.001642566,0.001347225,0.001083819,0.000366662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001843794,0.00005570372,0.000003896994,0.006028656,0.06308729,0.0005478422,0.0006178672,0.00001802378,4.419586e-7,0.00001624545,0.0005920472,0.9288476],"study_design_scores_gemma":[0.002313949,0.001379507,0.00004177297,0.01227668,0.03625181,0.00974753,0.001685496,0.000001537115,0.000002139121,0.00005542781,0.9356068,0.000637309],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005830814,0.9941607,0.001033548,0.00007770443,0.001382431,0.002227824,0.000111512,0.0001051964,0.0003179654],"genre_scores_gemma":[0.0004832413,0.993806,0.001528803,0.00009311886,0.003246463,0.0003675592,0.00003371573,0.0003380081,0.0001030808],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9350148,"threshold_uncertainty_score":0.9995269,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2600702237","doi":"10.1007/s40256-017-0224-5","title":"A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; Native Mental Health Association of Canada; University of British Columbia","funders":"","keywords":"Medicine; Spironolactone; Adverse effect; Placebo; Randomized controlled trial; Blood pressure; Internal medicine; Meta-analysis; MEDLINE; Clinical trial; Doxazosin; CINAHL; Intensive care medicine; Heart failure; Alternative medicine","authors":[{"name":"Anita Paula Tataru","is_ca":true},{"name":"Arden R. Barry","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09402899398896179,"gpt":0.3660618188573828,"spread":0.272032824868421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002820812,0.0004286372,0.0136787,0.0003064507,0.00005579794,0.000008170822,0.0004286547,0.00007995086,0.000007136543],"category_scores_gemma":[0.0002450549,0.0001805847,0.006777643,0.0003410408,0.0002900817,0.00003010076,0.00002275487,0.0003246405,0.000002933311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005477958,"about_ca_system_score_gemma":0.0003092744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004513039,"about_ca_topic_score_gemma":2.986208e-7,"domain_scores_codex":[0.9946759,0.001811068,0.001893011,0.0002344769,0.001186848,0.000198703],"domain_scores_gemma":[0.9941406,0.0007134172,0.00313998,0.001329737,0.0006022726,0.00007398834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001402003,0.000460428,4.8866e-7,0.3552504,0.02999572,0.0006259725,0.000280497,4.823363e-7,0.000001466518,0.000001386152,0.0006813966,0.6125616],"study_design_scores_gemma":[0.0009516903,0.002749454,0.000003958058,0.4271684,0.0604708,0.0008951502,0.000223414,1.017771e-7,0.000005627478,7.305438e-7,0.5074326,0.00009808743],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009069315,0.9972389,0.000001003759,0.0001671172,0.0001276111,0.002052154,0.00001166232,0.000003396497,0.0003074224],"genre_scores_gemma":[0.0009173617,0.9981126,0.00004880864,0.0006053874,0.0001793878,0.00007938332,0.000003571798,0.00003300655,0.00002048453],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6124635,"threshold_uncertainty_score":0.9350484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984187124","doi":"10.2165/00129784-200101060-00004","title":"Contemporary Management of Children with Atrial Septal Defects","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Toronto General Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intracardiac injection; Percutaneous; Surgery; Median sternotomy; Thoracotomy; Septum secundum; Shunt (medical); Volume overload; Cardiology; Internal medicine; Heart failure","authors":[{"name":"Rolf Bennhagen","is_ca":true},{"name":"Peter R. McLaughlin","is_ca":true},{"name":"Lee Benson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01845082342565623,"gpt":0.2756742241101734,"spread":0.2572234006845172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001240854,0.0005871332,0.0060972,0.0006228081,0.00006526762,0.00002838683,0.0004510794,0.0001568982,0.00001529103],"category_scores_gemma":[0.00002600639,0.0004232702,0.02765743,0.001550722,0.0003899447,0.00009984645,0.0001181724,0.0008193847,0.0000187825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001955973,"about_ca_system_score_gemma":0.0007946271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007081772,"about_ca_topic_score_gemma":1.304863e-7,"domain_scores_codex":[0.9956583,0.0005028956,0.001373287,0.0004616262,0.001653043,0.0003507807],"domain_scores_gemma":[0.9961037,0.00009179245,0.00150606,0.001502508,0.0004433758,0.0003525833],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001237616,0.0000793455,0.00007864596,0.001839253,0.1794697,0.0005165089,0.00004075822,0.0001543303,2.262624e-8,0.00001478887,0.0003136759,0.8173692],"study_design_scores_gemma":[0.004166348,0.0008503368,0.0002937836,0.01709131,0.1228433,0.0156042,0.0002066701,5.55966e-7,8.539049e-7,0.000003775195,0.8384681,0.0004708331],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000521938,0.9883698,0.002474108,0.00001119646,0.0001732689,0.001220071,0.0000235692,0.00003069308,0.007175419],"genre_scores_gemma":[0.009838743,0.9879853,0.001216891,0.00001629269,0.0006629772,0.00001579597,0.00007205832,0.0001265247,0.00006549029],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8381544,"threshold_uncertainty_score":0.9998219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220824635","doi":"10.1007/s40256-022-00526-9","title":"Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy","year":2022,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Transthyretin; Placebo; Internal medicine; Cardiomyopathy; Heart failure; Clinical trial; Pathology","authors":[{"name":"Mark H. Rozenbaum","is_ca":false},{"name":"Diana Tran","is_ca":true},{"name":"Rahul Bhambri","is_ca":false},{"name":"José Nativi-Nicolau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.001858187421048651,"gpt":0.1758355353900297,"spread":0.1739773479689811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001261734,0.0004946642,0.001385446,0.0003449162,0.0002024486,0.0000301545,0.0005100911,0.00008360701,0.00001665094],"category_scores_gemma":[0.00005373976,0.0004136513,0.001851328,0.001033478,0.0003500723,0.00004345921,0.0001330367,0.0004280426,0.000002404333],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002757829,"about_ca_system_score_gemma":0.0002910132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002139325,"about_ca_topic_score_gemma":0.000007026293,"domain_scores_codex":[0.9952911,0.001052041,0.0007194538,0.0006682036,0.001724236,0.000544982],"domain_scores_gemma":[0.9977351,0.00003153783,0.0005419822,0.001004179,0.000470496,0.0002167277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002582086,0.001037646,0.5768841,0.00004672713,0.03873722,0.0005042102,0.00339341,0.304379,0.0001739328,0.00001356912,0.0005012127,0.07174689],"study_design_scores_gemma":[0.04421977,0.02196797,0.7733845,0.00023261,0.01017693,0.001096257,0.02049824,0.00005028931,0.004820975,0.00002577135,0.120285,0.003241741],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872342,0.00869186,0.002851072,0.00009900808,0.0001819364,0.0006207699,0.0001651628,0.00002024006,0.0001357642],"genre_scores_gemma":[0.9979551,0.0007678107,0.0006105831,0.000123046,0.0001001038,0.0001106427,0.0001861423,0.0001236585,0.00002286456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3043287,"threshold_uncertainty_score":0.9998316,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531426511","doi":"10.1007/s40256-016-0196-x","title":"Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Mace; Internal medicine; Hazard ratio; Percutaneous coronary intervention; Acute coronary syndrome; Myocardial infarction; Clinical endpoint; Cardiology; Propensity score matching; Confidence interval; Clopidogrel; Randomized controlled trial","authors":[{"name":"Mario Iannaccone","is_ca":false},{"name":"Fabrizio D ́Ascenzo","is_ca":false},{"name":"Ovidio De Filippo","is_ca":false},{"name":"Marco Gagliardi","is_ca":false},{"name":"Danielle A. Southern","is_ca":true},{"name":"Sergio Raposeiras‐Roubín","is_ca":false},{"name":"Emad Abu‐Assi","is_ca":false},{"name":"Josè P.S. Henriques","is_ca":false},{"name":"Jorge Saucedo","is_ca":false},{"name":"José Ramón González‐Juanatey","is_ca":false},{"name":"Stephen B. Wilton","is_ca":true},{"name":"Wouter J. Kikkert","is_ca":false},{"name":"Iván J. Núñez‐Gil","is_ca":false},{"name":"Albert Ariza‐Solé","is_ca":false},{"name":"Xiantao Song","is_ca":false},{"name":"Dimitrios Alexopoulos","is_ca":false},{"name":"Christoph Liebetrau","is_ca":false},{"name":"Tetsuma Kawaji","is_ca":false},{"name":"Zenon Huczek","is_ca":false},{"name":"Shaoping Nie","is_ca":false},{"name":"Toshiharu Fujii","is_ca":false},{"name":"Luís Cláudio Lemos Correia","is_ca":false},{"name":"Masa‐aki Kawashiri","is_ca":false},{"name":"José María García‐Acuña","is_ca":false},{"name":"Emilio Alfonso","is_ca":false},{"name":"Belén Terol","is_ca":false},{"name":"Alberto Garay","is_ca":false},{"name":"Dongfeng Zhang","is_ca":false},{"name":"Yalei Chen","is_ca":false},{"name":"Ioanna Xanthopoulou","is_ca":false},{"name":"Neriman Osman","is_ca":false},{"name":"Helge Möllmann","is_ca":false},{"name":"Hiroki Shiomi","is_ca":false},{"name":"Michał Kowara","is_ca":false},{"name":"Krzysztof J. Filipiak‬","is_ca":false},{"name":"Xiao Wang","is_ca":false},{"name":"Yan Yan","is_ca":false},{"name":"Jingyao Fan","is_ca":false},{"name":"Yuji Ikari","is_ca":false},{"name":"Takuya Nakahashi","is_ca":false},{"name":"Kenji Sakata","is_ca":false},{"name":"Masakazu Yamagishi","is_ca":false},{"name":"Claudio Moretti","is_ca":false},{"name":"Fiorenzo Gaïta","is_ca":false},{"name":"Oliver Kalpak","is_ca":false},{"name":"Saško Kedev","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005686644324525907,"gpt":0.2400610851360142,"spread":0.2343744408114883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001064924,0.0002647359,0.00112741,0.0002493978,0.0000617675,0.00001721761,0.0001870316,0.00008808542,0.00002906228],"category_scores_gemma":[0.00007706184,0.0001734825,0.001126238,0.0002946335,0.0002123476,0.0002270239,0.0000295983,0.0002641265,0.000002410056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003426184,"about_ca_system_score_gemma":0.0003323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002508541,"about_ca_topic_score_gemma":0.000004385746,"domain_scores_codex":[0.9970322,0.0002883458,0.0006472199,0.0003244644,0.001369602,0.0003381384],"domain_scores_gemma":[0.998468,0.0001823051,0.0003574176,0.0003686551,0.0003835911,0.000240019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01104327,0.001944544,0.1570168,0.00006487807,0.02202019,0.004750483,0.001504692,0.0001998331,0.002051615,0.000004143903,0.00003849862,0.7993611],"study_design_scores_gemma":[0.08798701,0.06152232,0.7859502,0.004229732,0.004268422,0.04229601,0.006199108,0.00003831756,0.006117614,0.0000423345,0.0004169279,0.0009320154],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915741,0.0008855007,0.006031108,0.000264833,0.0001429446,0.001054543,0.000009340083,0.00002094375,0.00001668784],"genre_scores_gemma":[0.9975609,0.00124465,0.0008155701,0.0001623338,0.00009599635,0.0000295569,0.00000987981,0.00006277555,0.00001833636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.798429,"threshold_uncertainty_score":0.707441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W167127537","doi":"10.1007/bf03256594","title":"Extended Dalteparin Prophylaxis for Venous Thromboembolic Events","year":2009,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Royal Jubilee Hospital; Toronto East General Hospital; Sunnybrook Health Science Centre; Augmentium Pharma Consulting (Canada)","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Warfarin; Pulmonary embolism; Arthroplasty; Knee replacement; Venous thrombosis; Orthopedic surgery; Deep vein; Hip fracture; Hip replacement; Thrombosis; Surgery; Anesthesia; Internal medicine; Atrial fibrillation","authors":[{"name":"George Dranitsaris","is_ca":true},{"name":"Carmine Stumpo","is_ca":true},{"name":"Reginald E. Smith","is_ca":true},{"name":"William R. Bartle","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008735250268885322,"gpt":0.266173251892355,"spread":0.2574380016234697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001111215,0.0002613534,0.001880424,0.0002779986,0.000118098,0.00002574958,0.0002201344,0.00005300531,0.00001398237],"category_scores_gemma":[0.0001186765,0.0002145325,0.002116082,0.0003953069,0.0001140131,0.0001337678,0.00003251534,0.0002615851,0.00001181445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001623611,"about_ca_system_score_gemma":0.0001999734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004414701,"about_ca_topic_score_gemma":3.533505e-7,"domain_scores_codex":[0.9975566,0.0001237619,0.0006293367,0.0002969046,0.0009285326,0.0004649053],"domain_scores_gemma":[0.9981624,0.00003994447,0.0004279459,0.0006397332,0.0004309187,0.0002990661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002986486,0.00182151,0.000165917,0.00009278076,0.006096858,0.0002365268,0.001062738,0.000490986,0.0003358069,0.0003761099,0.001805907,0.9872162],"study_design_scores_gemma":[0.0146868,0.05390907,0.5380393,0.0009438741,0.01544466,0.003511795,0.003968342,0.0001296715,0.003831831,0.004094467,0.360061,0.001379185],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798012,0.007229221,0.007892717,0.001099004,0.0004772634,0.00118365,0.000005925246,0.00004781668,0.002263176],"genre_scores_gemma":[0.9920164,0.001765251,0.004474715,0.0009194897,0.0007130995,0.00002219681,0.000005413325,0.00004177103,0.0000416537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.985837,"threshold_uncertainty_score":0.8748383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996384645","doi":"10.1007/s40256-013-0049-9","title":"New Drug Avenues for Cardioprotection in Patients with Acute Myocardial Infarction","year":2013,"lang":"en","type":"letter","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Cardioprotection; Medicine; Myocardial infarction; Reperfusion injury; Cardiology; Heart failure; Internal medicine; Pharmacology; Ischemia; Intensive care medicine","authors":[{"name":"François Roubille","is_ca":true},{"name":"Alain Lacampagne","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.002722940025025078,"gpt":0.1961345817209559,"spread":0.1934116416959309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006307311,0.0004639385,0.00238602,0.0006211153,0.00006837671,0.00005131095,0.0001665923,0.0003385584,0.000009562586],"category_scores_gemma":[0.00005377407,0.0003491941,0.003665497,0.0004567404,0.0001479547,0.0002033429,0.00004237223,0.001932049,0.000009293304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000482821,"about_ca_system_score_gemma":0.0005964019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005785602,"about_ca_topic_score_gemma":5.602363e-7,"domain_scores_codex":[0.9964863,0.0002280535,0.0006953664,0.0004373137,0.001690287,0.0004626489],"domain_scores_gemma":[0.9974528,0.00006802131,0.0007379235,0.0006674087,0.0008788061,0.0001950579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002026098,0.00005833223,0.004091287,0.0002273248,0.03062002,0.0004048383,0.0008880208,0.0004481756,0.00007789806,3.414971e-7,0.5882303,0.3729274],"study_design_scores_gemma":[0.008504762,0.001539492,0.007486661,0.000742466,0.009400144,0.001011804,0.0001769248,0.000004346036,0.0004100697,0.00001321166,0.9701612,0.0005489292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9002563,0.005608603,0.007064003,0.07713064,0.004188615,0.004810939,0.00007149951,0.00007750582,0.0007919368],"genre_scores_gemma":[0.6552963,0.008539698,0.03028193,0.1648116,0.1306276,0.0007988228,0.001862067,0.001918629,0.005863451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3819309,"threshold_uncertainty_score":0.999896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W32461932","doi":"10.2165/00129784-200101050-00001","title":"Antiatherosclerotic Effects of ACE Inhibitors","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Blood pressure; Internal medicine; ACE inhibitor; Endothelium; Aldosterone; Renin–angiotensin system; Heart failure; Clinical trial; Angiotensin-converting enzyme; Pharmacology","authors":[{"name":"Eva Lonn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01834815467841917,"gpt":0.2797059348951353,"spread":0.2613577802167161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008536046,0.0004597208,0.008980133,0.0004436795,0.00004578764,0.00001151133,0.0002464542,0.0001475831,0.000007035976],"category_scores_gemma":[0.000186786,0.0003069525,0.007545198,0.0008620119,0.000383246,0.0000603624,0.00009559788,0.0007195389,0.00001299059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003373385,"about_ca_system_score_gemma":0.0003523249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000032737,"about_ca_topic_score_gemma":8.910429e-8,"domain_scores_codex":[0.996628,0.0004980735,0.001156368,0.0002751121,0.001138749,0.0003037209],"domain_scores_gemma":[0.9967192,0.0003922688,0.001392773,0.0007370263,0.0005386159,0.0002201577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001918372,0.0000959098,0.000009631835,0.009343178,0.03645931,0.0005495715,0.0001707347,0.000002534277,0.000002083455,0.000001237211,0.002409156,0.9509374],"study_design_scores_gemma":[0.0008077821,0.0006407524,0.00001544865,0.0267732,0.08003689,0.002547019,0.0001580753,1.227564e-7,0.00003896021,0.000001711892,0.8887594,0.0002206201],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001731984,0.9983441,0.00009918365,0.0000572437,0.0005391587,0.0004775409,0.000002723667,0.00001392204,0.000292923],"genre_scores_gemma":[0.0009033862,0.9972104,0.0006410954,0.0001236814,0.0009532204,0.000007826776,0.000002152777,0.00008817099,0.00007003058],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9507169,"threshold_uncertainty_score":0.9999382,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2799686913","doi":"10.1007/s40256-018-0273-4","title":"Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Myocardial infarction; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Clinical endpoint; Propensity score matching; Cardiology; Ejection fraction; Unstable angina; Revascularization; Heart failure; Acute coronary syndrome; Randomized controlled trial","authors":[{"name":"Fabrizio D’Ascenzo","is_ca":false},{"name":"Dario Celentani","is_ca":false},{"name":"Alessandro Brustio","is_ca":false},{"name":"Alberto Grosso","is_ca":false},{"name":"Sergio Raposeiras‐Roubín","is_ca":false},{"name":"Emad Abu‐Assi","is_ca":false},{"name":"Josè P.S. Henriques","is_ca":false},{"name":"Jorge Saucedo","is_ca":false},{"name":"José Ramón González‐Juanatey","is_ca":false},{"name":"Stephen B. Wilton","is_ca":true},{"name":"Wouter J. Kikkert","is_ca":false},{"name":"Iván J. Núñez‐Gil","is_ca":false},{"name":"Albert Ariza‐Solé","is_ca":false},{"name":"Xiantao Song","is_ca":false},{"name":"Dimitrios Alexopoulos","is_ca":false},{"name":"Christoph Liebetrau","is_ca":false},{"name":"Tetsuma Kawaji","is_ca":false},{"name":"Zenon Huczek","is_ca":false},{"name":"Shaoping Nie","is_ca":false},{"name":"Toshiharu Fujii","is_ca":false},{"name":"Luis Correia","is_ca":false},{"name":"Masa‐aki Kawashiri","is_ca":false},{"name":"José María García‐Acuña","is_ca":false},{"name":"Danielle A. Southern","is_ca":true},{"name":"Emilio Alfonso","is_ca":false},{"name":"Belén Terol","is_ca":false},{"name":"Alberto Garay","is_ca":false},{"name":"Dongfeng Zhang","is_ca":false},{"name":"Yalei Chen","is_ca":false},{"name":"Ioanna Xanthopoulou","is_ca":false},{"name":"Neriman Osman","is_ca":false},{"name":"Helge Möllmann","is_ca":false},{"name":"Hiroki Shiomi","is_ca":false},{"name":"Michał Kowara","is_ca":false},{"name":"Krzysztof J. Filipiak‬","is_ca":false},{"name":"Xiao Wang","is_ca":false},{"name":"Yan Yan","is_ca":false},{"name":"Jingyao Fan","is_ca":false},{"name":"Yuji Ikari","is_ca":false},{"name":"Takuya Nakahayshi","is_ca":false},{"name":"Kenji Sakata","is_ca":false},{"name":"Masakazu Yamagishi","is_ca":false},{"name":"Oliver Kalpak","is_ca":false},{"name":"Saško Kedev","is_ca":false},{"name":"Claudio Moretti","is_ca":false},{"name":"Maurizio D’Amico","is_ca":false},{"name":"Fiorenzo Gaita","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01633300958212757,"gpt":0.24719895070363,"spread":0.2308659411215024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001430364,0.0002362432,0.001390168,0.0002382016,0.0001535723,0.00004848167,0.0002507283,0.00005665001,0.00001360735],"category_scores_gemma":[0.000194447,0.0001195264,0.0007417643,0.001970534,0.0006701804,0.0001317437,0.00004792198,0.0005194927,0.000002953789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002664056,"about_ca_system_score_gemma":0.0003108344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002207929,"about_ca_topic_score_gemma":0.00005616697,"domain_scores_codex":[0.9952682,0.0006836148,0.0004478532,0.0003120801,0.002959752,0.000328457],"domain_scores_gemma":[0.9946443,0.0002501697,0.001146296,0.0008217445,0.002948391,0.0001890822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003547488,0.0001169048,0.911998,0.000009697621,0.07925759,0.0000614596,0.0005268346,0.0007843098,0.00002505437,6.951922e-7,0.0007665806,0.002905421],"study_design_scores_gemma":[0.005770405,0.004782202,0.9515001,0.0002220218,0.02747268,0.00006753077,0.001548065,0.00006197989,0.003297389,9.378974e-7,0.005029787,0.0002469574],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966539,0.00008188361,0.0005744904,0.001593616,0.00003064854,0.0004192994,0.00002493851,0.00001381447,0.0006074035],"genre_scores_gemma":[0.998502,0.00006761686,0.0007303396,0.0002099057,0.0003120702,0.000006447638,0.00002846106,0.0000376496,0.0001054719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0517849,"threshold_uncertainty_score":0.4874146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386100303","doi":"10.1007/s40256-023-00604-6","title":"Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Universidade de Santiago de Compostela; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Instituto de Investigación Sanitaria de Santiago de Compostela; Fundación Instituto de Investigación Sanitaria de Santiago de Compostela","keywords":"Alirocumab; Evolocumab; Medicine; PCSK9; Internal medicine; Observational study; Cognition; Cognitive decline; Cholesterol; Lipoprotein; Dementia; LDL receptor; Psychiatry; Disease","authors":[{"name":"José Seijas‐Amigo","is_ca":false},{"name":"Maria José Mauriz-Montero","is_ca":false},{"name":"Pedro Suárez‐Artime","is_ca":false},{"name":"Mónica Gayoso‐Rey","is_ca":false},{"name":"Ana Estany-Gestal","is_ca":false},{"name":"Antonia Casas-Martínez","is_ca":false},{"name":"Lara González-Freire","is_ca":false},{"name":"Ana Rodriguez-Vazquez","is_ca":false},{"name":"Natalia Pérez-Rodríguez","is_ca":false},{"name":"Laura Villaverde-Piñeiro","is_ca":false},{"name":"Concepción Castro-Rubinos","is_ca":false},{"name":"Esther Espino-Faisán","is_ca":false},{"name":"Moisés Rodríguez‐Mañero","is_ca":false},{"name":"Alberto Cordero","is_ca":false},{"name":"José Ramón González‐Juanatey","is_ca":false},{"name":"Adrián Paz-Couce","is_ca":false},{"name":"Diego Rodríguez‐Penas","is_ca":false},{"name":"Begoña Cardeso-Paredes","is_ca":false},{"name":"Ana Seoane‐Blanco","is_ca":false},{"name":"María Moure‐González","is_ca":false},{"name":"Rita Soler-Martín","is_ca":false},{"name":"Luis Margusino‐Framiñán","is_ca":false},{"name":"Ana Suarez-Rodriguez","is_ca":false},{"name":"Marisol Rodríguez-Cobos","is_ca":false},{"name":"J Rojo-Valdés","is_ca":false},{"name":"Irene Zarra‐Ferro","is_ca":false},{"name":"Karina Lorenzo‐Lorenzo","is_ca":false},{"name":"Cristina Casanova‐Martínez","is_ca":false},{"name":"Carlos Crespo-Diz","is_ca":false},{"name":"María Dominguez-Guerra","is_ca":false},{"name":"María Elena González-Pereira","is_ca":false},{"name":"María Anido-García","is_ca":false},{"name":"Iveth Michelle Tajes-Gonzalez","is_ca":false},{"name":"Héctor Mozo-Peñalver","is_ca":false},{"name":"Alicia Silva-Lopez","is_ca":false},{"name":"J. L. Rodríguez-Sánchez","is_ca":false},{"name":"María Jesús García-Verde","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02619071957199558,"gpt":0.3075683294849671,"spread":0.2813776099129715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004209565,0.0002479619,0.0008299592,0.000714987,0.0001552907,0.00007726832,0.0001880969,0.00002123636,0.00002277776],"category_scores_gemma":[0.000193657,0.0001551525,0.000604816,0.003304169,0.0002380563,0.0002744985,0.00006702983,0.0006642213,0.00002094754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001453744,"about_ca_system_score_gemma":0.0004556924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004793722,"about_ca_topic_score_gemma":0.0002790492,"domain_scores_codex":[0.9946164,0.001075444,0.0005447614,0.000369759,0.002980901,0.0004127513],"domain_scores_gemma":[0.997845,0.0003117759,0.0002723899,0.0003100056,0.001114796,0.0001460551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004418141,0.001616222,0.9367515,0.00001168877,0.008148112,0.001345674,0.01259832,0.00005161603,0.000009801088,0.000004707645,0.0001663288,0.03487792],"study_design_scores_gemma":[0.01141124,0.0118821,0.7675428,0.0001266808,0.00231874,0.0000672181,0.2061604,0.00001069181,0.0000246922,0.00001950704,0.0003060634,0.0001298111],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950032,0.0001425509,0.0001403801,0.0002702807,0.0001925164,0.002462597,0.000004915892,0.00002896962,0.001754583],"genre_scores_gemma":[0.9987233,0.00004556362,0.00002581834,0.0001179176,0.0004729801,0.0002202944,0.0000140873,0.00003473696,0.0003453616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1935621,"threshold_uncertainty_score":0.6326935,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977491200","doi":"10.2165/00129784-200303010-00001","title":"Does Ischemic Preconditioning Afford Clinically Relevant Cardioprotection?","year":2003,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cardioprotection; Ischemic preconditioning; Pharmacotherapy; Cardiology; Intensive care medicine; Internal medicine; Ischemia","authors":[{"name":"Peter Mikhail","is_ca":true},{"name":"Subodh Verma","is_ca":true},{"name":"Paul W.M. Fedak","is_ca":true},{"name":"Richard D. Weisel","is_ca":true},{"name":"Ren‐Ke Li","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0115327442342041,"gpt":0.2944760659873623,"spread":0.2829433217531582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00318432,0.0006970507,0.007751969,0.0005079785,0.0001450795,0.00005799433,0.0002919261,0.0004104159,0.00006416631],"category_scores_gemma":[0.0004046815,0.000387658,0.01831968,0.0007973352,0.0004166193,0.000138116,0.00008763696,0.002115983,0.0000464436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004562176,"about_ca_system_score_gemma":0.001443419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001923885,"about_ca_topic_score_gemma":8.108424e-8,"domain_scores_codex":[0.9942634,0.0007727272,0.002321912,0.0006340156,0.001506184,0.0005017424],"domain_scores_gemma":[0.995187,0.0002677398,0.002123013,0.00126073,0.0006835182,0.0004780093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007522595,0.00005216663,0.000009881654,0.003193808,0.01605,0.0002482799,0.00007525696,0.00002573145,0.000008778276,0.000001363214,0.0009806729,0.9792789],"study_design_scores_gemma":[0.0009037154,0.0006017727,0.00000159259,0.01330351,0.02500112,0.014261,0.0003222855,4.33868e-7,0.00008073284,0.000005161553,0.9450373,0.0004813873],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009309701,0.990734,0.0007590223,0.00004731531,0.001959913,0.0008636384,0.0000169524,0.00004295171,0.004645261],"genre_scores_gemma":[0.0004411025,0.9937773,0.002419068,0.00006774918,0.00241483,0.0000500473,0.00003089722,0.0001684008,0.000630654],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9787974,"threshold_uncertainty_score":0.9998575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390345179","doi":"10.1007/s40256-023-00620-6","title":"The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton General Hospital; Impact; McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"Boston Scientific Corporation; Novo Nordisk; Sanofi; Bayer; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Rivaroxaban; Medicine; Aspirin; Discontinuation; Cost effectiveness; Stroke (engine); Coronary artery disease; Regimen; Population; Myocardial infarction; Internal medicine; Surgery; Anesthesia; Warfarin; Atrial fibrillation","authors":[{"name":"André Lamy","is_ca":true},{"name":"John W. Eikelboom","is_ca":true},{"name":"Wesley Tong","is_ca":true},{"name":"Fei Yuan","is_ca":true},{"name":"Shrikant I. Bangdiwala","is_ca":true},{"name":"Jackie Bosch","is_ca":true},{"name":"Stuart J. Connolly","is_ca":true},{"name":"Eva Lonn","is_ca":true},{"name":"Gilles R. Dagenais","is_ca":true},{"name":"Kelley R. Branch","is_ca":false},{"name":"Wei‐Jhih Wang","is_ca":false},{"name":"Deepak L. Bhatt","is_ca":false},{"name":"Jeffrey L. Probstfield","is_ca":false},{"name":"Georg Ertl","is_ca":false},{"name":"Stefan Störk","is_ca":false},{"name":"Philippe Gabríel Steg","is_ca":false},{"name":"Victor Aboyans","is_ca":false},{"name":"Isabelle Durand‐Zaleski","is_ca":false},{"name":"Lars Rydén","is_ca":false},{"name":"Salim Yusuf","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04505284589782036,"gpt":0.335005160030622,"spread":0.2899523141328016,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005298148,0.0002033983,0.001348421,0.0003093189,0.0001161331,0.00004198846,0.0003332417,0.00002890614,0.000002874982],"category_scores_gemma":[0.0002236973,0.0001071625,0.001182613,0.001642175,0.0004811134,0.00009872994,0.000058502,0.0003254917,0.00000746975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002399868,"about_ca_system_score_gemma":0.0002159892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004973476,"about_ca_topic_score_gemma":0.00001694809,"domain_scores_codex":[0.9962317,0.001416655,0.0005873651,0.0001980504,0.001274611,0.0002915589],"domain_scores_gemma":[0.997128,0.001267259,0.0005149929,0.000563718,0.0004393005,0.00008670407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3335087,0.0003682695,0.1575527,0.0006764029,0.06380692,0.002378599,0.02854875,0.2455568,0.0003868435,0.006582611,0.001433778,0.1591996],"study_design_scores_gemma":[0.1406838,0.005005107,0.6968007,0.0008433266,0.004297049,0.0004232887,0.07011645,0.0009175983,0.0004064134,0.0003453853,0.07964829,0.0005126208],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919138,0.001363924,0.001048265,0.002253304,0.0002414976,0.001874709,0.00000330075,0.00002517443,0.00127605],"genre_scores_gemma":[0.9990585,0.0002943691,0.0001012932,0.00007091054,0.0003922167,0.00001747158,0.000005455609,0.00002740243,0.00003233607],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.539248,"threshold_uncertainty_score":0.4369961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W68433167","doi":"10.2165/00129784-200101020-00002","title":"Patients With Atherosclerotic Vascular Disease","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Homocysteine; Medicine; Internal medicine; Vascular disease; B vitamins; Fibrinogen; Risk factor; Vitamin B12; Endocrinology; Cyanocobalamin; Endothelial dysfunction; Pyridoxine; Stroke (engine); Niacin","authors":[{"name":"J. David Spence","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01629767700911423,"gpt":0.2832426859816138,"spread":0.2669450089724996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009863352,0.0005865195,0.004862368,0.0006403377,0.00007622151,0.00005473079,0.0004475554,0.00009299706,0.00005868216],"category_scores_gemma":[0.000139186,0.0003559013,0.006806803,0.001389395,0.0004277188,0.0001403535,0.00008287387,0.001053571,0.00007784835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000330556,"about_ca_system_score_gemma":0.001227484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003339962,"about_ca_topic_score_gemma":1.308335e-7,"domain_scores_codex":[0.9947608,0.0005738507,0.0009248256,0.0004406805,0.002730887,0.0005690007],"domain_scores_gemma":[0.9961064,0.0001049817,0.0007236913,0.001279179,0.0008454971,0.0009402431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001192634,0.0002479841,0.0003178963,0.002893224,0.01955126,0.0006895066,0.00003834235,0.0000169865,9.105178e-9,8.497761e-7,0.0001638617,0.9759608],"study_design_scores_gemma":[0.001870388,0.001204354,0.001024071,0.0123203,0.02439453,0.0002930163,0.00005029036,0.000001038755,7.430138e-8,0.000001240306,0.9584721,0.0003685507],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001878724,0.9965372,0.000237531,0.0000247095,0.0001179387,0.0008933235,0.00001579083,0.00001817018,0.0002765782],"genre_scores_gemma":[0.000562703,0.998093,0.0003242878,0.00008475608,0.0005536399,0.00002200235,0.0000474167,0.0001732059,0.0001389549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9755923,"threshold_uncertainty_score":0.9998893,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2436268523","doi":"10.1007/s40256-016-0177-0","title":"Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"Canadian Institutes of Health Research; Pfizer Canada; Pfizer","keywords":"Eplerenone; Medicine; Context (archaeology); Heart failure; Cost effectiveness; Intensive care medicine; Spironolactone; Internal medicine; Cardiology","authors":[{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Justin A. Ezekowitz","is_ca":true},{"name":"Dat T. Tran","is_ca":true},{"name":"Padma Kaul","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009846662652232397,"gpt":0.2365319949996298,"spread":0.2266853323473974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004409274,0.0001212654,0.001012479,0.00009788095,0.00002267494,0.000002107376,0.00006511513,0.00002170342,0.000004443325],"category_scores_gemma":[0.00005324518,0.00005376361,0.0005311951,0.0002108293,0.0001742378,0.00003268171,0.000004694329,0.00004510231,2.967808e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002739384,"about_ca_system_score_gemma":0.0006330275,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1186771,"about_ca_topic_score_gemma":0.01527627,"domain_scores_codex":[0.9987503,0.0001679162,0.0003183942,0.0001073912,0.0005114213,0.0001445931],"domain_scores_gemma":[0.9982303,0.0007800524,0.0002169353,0.0002885153,0.0003854862,0.00009875163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01228053,0.0008410451,0.07480127,0.0004319901,0.02845931,0.0001560438,0.001697499,0.006175739,0.01043823,0.0001981141,0.0005337645,0.8639864],"study_design_scores_gemma":[0.02881839,0.009126676,0.6503406,0.003023919,0.004883767,0.001748748,0.001955383,0.0001513338,0.0338318,0.00001164355,0.2657719,0.0003359044],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936092,0.002925677,0.001664352,0.001165762,0.0000463515,0.0005544909,0.000008031424,0.000001343416,0.00002480332],"genre_scores_gemma":[0.9992855,0.0003386346,0.0002269698,0.00003531119,0.00005566702,0.00001766614,0.000001248286,0.00001684177,0.00002217599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8636506,"threshold_uncertainty_score":0.8871917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024206888","doi":"10.1007/s40256-013-0018-3","title":"Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole","year":2013,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Omeprazole; Medicine; Proton-pump inhibitor; Pharmacology; Pharmacodynamics; Pharmacokinetics; Dipyridamole; Aspirin; Drug interaction; CYP2C19; Crossover study; Clopidogrel; Anesthesia; Internal medicine","authors":[{"name":"Elliot Offman","is_ca":true},{"name":"Michael J. Schobelock","is_ca":false},{"name":"R Brickl","is_ca":false},{"name":"Cam P. VanderMaelen","is_ca":false},{"name":"Jerome Ehrlich","is_ca":false},{"name":"Wolfgang G. Eisert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004512241784459435,"gpt":0.2175551910978554,"spread":0.2130429493133959,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007271917,0.0003136658,0.0009594146,0.0001031427,0.0001650696,0.00006770525,0.0002836901,0.00005685383,0.00001389334],"category_scores_gemma":[0.00003343928,0.0001825037,0.001165829,0.0004431502,0.0007377977,0.0002355213,0.00006601789,0.0004529431,0.000002863443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008568155,"about_ca_system_score_gemma":0.0002027798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005680023,"about_ca_topic_score_gemma":7.45008e-7,"domain_scores_codex":[0.9971002,0.0004454783,0.0005611365,0.0002722519,0.001323602,0.0002973516],"domain_scores_gemma":[0.9977215,0.00006571501,0.0007968717,0.00057447,0.0005953613,0.0002460681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005447149,0.001557703,0.004843868,0.0006253248,0.03917138,0.000320664,0.00226981,0.01016244,0.1151004,0.000109555,0.006310657,0.8140811],"study_design_scores_gemma":[0.0701625,0.007367394,0.1526279,0.001954069,0.03013722,0.01034647,0.02206326,0.01267985,0.6249765,0.000120373,0.06521983,0.002344669],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847358,0.008172095,0.003936451,0.002151376,0.0001714718,0.0007177741,0.00003712972,0.00001811723,0.00005971806],"genre_scores_gemma":[0.9960936,0.002680552,0.000110472,0.0007514644,0.0002403963,0.00002875037,0.00001577397,0.0000510028,0.00002802554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8117364,"threshold_uncertainty_score":0.7442284,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067005179","doi":"10.1007/s40256-013-0009-4","title":"Pharmacologic Treatment of Hypertension in Patients With Chronic Kidney Disease","year":2013,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Kidney disease; Etiology; Disease; Intensive care medicine; Blood pressure; Pharmacotherapy; Population; Internal medicine; Kidney","authors":[{"name":"Hari Talreja","is_ca":true},{"name":"Marcel Ruzicka","is_ca":true},{"name":"Brendan McCormick","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02815821034611904,"gpt":0.2755324716003946,"spread":0.2473742612542756,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002479743,0.0004672791,0.006566787,0.0004223894,0.00003280871,0.000008056983,0.0001438916,0.00006368728,0.00003001753],"category_scores_gemma":[0.00004461638,0.0002469639,0.002880013,0.000455962,0.0002742462,0.00007168092,0.00004327891,0.0002907489,0.00001089711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001816673,"about_ca_system_score_gemma":0.001019157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008450939,"about_ca_topic_score_gemma":2.002321e-7,"domain_scores_codex":[0.9972732,0.0003648344,0.0009006373,0.000304259,0.0008669968,0.0002900367],"domain_scores_gemma":[0.9973673,0.0001077066,0.0009134578,0.0005406203,0.0006163963,0.0004544706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000236164,0.000620142,0.0004846033,0.002244201,0.02250963,0.000423697,0.0000542831,0.00001167923,2.242434e-7,1.989504e-7,0.00122566,0.9721895],"study_design_scores_gemma":[0.005002336,0.003008173,0.000974321,0.008007861,0.0649956,0.000151638,0.00003674741,0.000001009245,0.000002165267,4.872899e-7,0.917592,0.0002275829],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002733751,0.9959306,0.000004627265,0.00009673292,0.0001668118,0.0009859762,0.00002006606,0.000007714029,0.00005372519],"genre_scores_gemma":[0.005536868,0.9935288,0.0001843666,0.0002725731,0.0003225443,0.00004097987,0.00002558836,0.00005678924,0.00003145262],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9719619,"threshold_uncertainty_score":0.9999983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982900042","doi":"10.2165/00129784-200606060-00003","title":"Intensive Reduction of Low-Density Lipoprotein-Cholesterol","year":2006,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Cholesterol; Statin; Coronary artery disease; Internal medicine; Randomized controlled trial; Pharmacotherapy; Placebo; Disease; Clinical trial; Cardiology; Intensive care medicine; Pathology","authors":[{"name":"Daniel G. Hackam","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01478846698119033,"gpt":0.2823904842206749,"spread":0.2676020172394845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.003115268,0.0007561749,0.01011954,0.0008480402,0.00007997127,0.00003196768,0.0004095574,0.0003356599,0.000009610073],"category_scores_gemma":[0.0003345743,0.000578022,0.0165915,0.001155037,0.0006290582,0.0001572115,0.000116614,0.001549372,0.00001819433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005187837,"about_ca_system_score_gemma":0.001558393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001602822,"about_ca_topic_score_gemma":0.000001894903,"domain_scores_codex":[0.9928194,0.001098892,0.002399209,0.0006007581,0.002538733,0.0005429943],"domain_scores_gemma":[0.9917516,0.00008251682,0.002986809,0.00200823,0.00273201,0.0004388812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008125226,0.00009745837,0.000001517548,0.01115581,0.01619313,0.000275464,0.0001434349,0.00003113737,0.000002805173,0.000003291963,0.0003129571,0.9717017],"study_design_scores_gemma":[0.001540068,0.001128154,0.00008142395,0.02623066,0.02659981,0.01946989,0.000656996,8.987939e-7,0.0001656633,0.00001095538,0.9235892,0.0005263218],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00315678,0.9930286,0.001206242,0.00005147683,0.0007256966,0.001458092,0.00001868163,0.00002825862,0.0003261926],"genre_scores_gemma":[0.006102751,0.9897876,0.0009345204,0.000061343,0.002807037,0.00003074746,0.0000352003,0.0001688323,0.00007201567],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9711754,"threshold_uncertainty_score":0.9996671,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984682492","doi":"10.2165/00129784-200707010-00006","title":"Current Management of Transient Ischemic Attack","year":2007,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Carotid endarterectomy; Dipyridamole; Stroke (engine); Stenosis; Cardiology; Internal medicine; Magnetic resonance imaging; Endarterectomy; Carotid stenting; Surgery; Radiology","authors":[{"name":"Padmavathy N. Sylaja","is_ca":true},{"name":"Michael D. Hill","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02972479735377029,"gpt":0.3346014572548225,"spread":0.3048766599010523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001326738,0.0005618783,0.005402477,0.0005823946,0.00003234135,0.00001532842,0.0004046657,0.00008914787,0.00004575601],"category_scores_gemma":[0.0000136067,0.0004267105,0.01597036,0.0008469823,0.0003471848,0.0000707216,0.00006894885,0.0006738348,0.00002254143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000221079,"about_ca_system_score_gemma":0.0004374202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005352799,"about_ca_topic_score_gemma":6.046657e-8,"domain_scores_codex":[0.9953455,0.0002719489,0.001660801,0.0003959613,0.001899782,0.0004260503],"domain_scores_gemma":[0.9969245,0.00006266293,0.001090245,0.001077376,0.0003889661,0.0004562577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003492404,0.0002253046,0.00000875468,0.02011388,0.026882,0.0001385237,0.00009154181,0.00001831124,1.05109e-7,0.000003334155,0.001142357,0.951341],"study_design_scores_gemma":[0.00111248,0.0002918565,0.00006517773,0.02745187,0.04614376,0.001562314,0.0004635635,4.124862e-7,0.000004660578,2.989765e-7,0.9225829,0.0003207062],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004618328,0.9943045,0.001117772,0.000007502915,0.0004464932,0.0007109666,0.00002172396,0.00001521986,0.002914038],"genre_scores_gemma":[0.0008936819,0.9978795,0.0005218206,0.00002086922,0.0005049378,0.00001465138,0.00003554282,0.00009490263,0.00003406003],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9510202,"threshold_uncertainty_score":0.9998184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901198550","doi":"10.1007/s40256-018-0309-9","title":"Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; The Quebec Population Health Research Network; Université du Québec à Trois-Rivières; Université Laval; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Abbott Vascular; Institut National de Santé Publique du Québec","keywords":"Medicine; Warfarin; Population; Pharmacotherapy; Brand names; Series (stratigraphy); Advertising; Internal medicine; Atrial fibrillation; Business; Environmental health","authors":[{"name":"Jacinthe Leclerc","is_ca":true},{"name":"Claudia Blais","is_ca":true},{"name":"Louis Rochette","is_ca":true},{"name":"Denis Hamel","is_ca":true},{"name":"Line Guénette","is_ca":true},{"name":"Paul Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01018857307148761,"gpt":0.226260074158103,"spread":0.2160715010866154,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007267672,0.0001535022,0.001061814,0.0008711441,0.00004546652,0.00004184659,0.000166543,0.00003623728,0.00005968447],"category_scores_gemma":[0.00005914619,0.0001709661,0.0006027531,0.0008794681,0.00009496031,0.0001796684,0.00002210361,0.000121472,0.000003237637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004222453,"about_ca_system_score_gemma":0.0002002516,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4250155,"about_ca_topic_score_gemma":0.1643688,"domain_scores_codex":[0.9986258,0.00004163837,0.0007275429,0.0002529019,0.00006646905,0.0002857214],"domain_scores_gemma":[0.9991139,0.00006969649,0.0004023438,0.0002136105,0.00005158185,0.0001489297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00038089,0.0001633316,0.7855377,0.00003230806,0.008044674,0.00003659111,0.001537635,0.05631985,0.0000039395,0.0009020212,0.001109826,0.1459313],"study_design_scores_gemma":[0.003311759,0.0005171231,0.8253762,0.00001974549,0.0004983217,0.00001321461,0.00017375,0.03402559,0.00003476087,0.0004570123,0.1349387,0.0006338088],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928324,0.003127323,0.0006746109,0.002768767,0.0001097221,0.00008492375,0.0000868754,0.000003514309,0.0003118732],"genre_scores_gemma":[0.9985211,0.0002002409,0.0005695286,0.0004884534,0.0001448991,0.000006847262,0.00001084789,0.00001982877,0.00003820318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2606467,"threshold_uncertainty_score":0.8508793,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067166093","doi":"10.1007/s40256-014-0087-y","title":"Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management","year":2014,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Servier","keywords":"Medicine; Amlodipine; Blood pressure; Thiazide; Atenolol; Calcium channel blocker; Indapamide; Internal medicine; Pharmacology; Renin–angiotensin system; Aldosterone; Intensive care medicine; Combination therapy; Diuretic; Guideline; Cardiology","authors":[{"name":"Michel E. Safar","is_ca":true},{"name":"Jacques Blacher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03978379724556352,"gpt":0.3032865031966991,"spread":0.2635027059511356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001901744,0.0006289422,0.007439529,0.000654975,0.0001658966,0.00004032954,0.000325487,0.000188761,0.000008850378],"category_scores_gemma":[0.00009008891,0.0004376446,0.007090477,0.0004968958,0.0002099751,0.00008408188,0.0001609206,0.0005688581,0.00003193267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007970013,"about_ca_system_score_gemma":0.0001475161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001683753,"about_ca_topic_score_gemma":1.604526e-7,"domain_scores_codex":[0.9959442,0.0004159744,0.001336483,0.00051077,0.00132762,0.0004649549],"domain_scores_gemma":[0.9961905,0.0002497063,0.001234127,0.0009037557,0.001137268,0.000284625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008632855,0.0001755115,7.080909e-7,0.007656293,0.04642671,0.0002937848,0.00009802834,0.000004604894,1.491289e-7,0.00002119238,0.03660752,0.9086292],"study_design_scores_gemma":[0.002607138,0.0006625595,0.000008554314,0.009504396,0.1024597,0.002120435,0.0003614369,0.00001952469,0.000001905591,0.00002374595,0.8818561,0.0003745324],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001534247,0.9932407,0.003178305,0.0003985351,0.001064404,0.001454977,0.00001260625,0.00003379689,0.0006013499],"genre_scores_gemma":[0.0004775187,0.9939888,0.00197036,0.001694845,0.001107704,0.000110111,0.00004213382,0.0001417424,0.000466748],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9082546,"threshold_uncertainty_score":0.9998075,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3185695548","doi":"10.1007/s40256-021-00489-3","title":"The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery","year":2021,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Population Health Research Institute; Université de Montréal; Impact; Hamilton Health Sciences; Queen's University; McMaster University","funders":"","keywords":"Medicine; Dabigatran; Pharmacotherapy; Cardiac surgery; Cardiology; Surgery; Internal medicine; Atrial fibrillation; Warfarin","authors":[{"name":"André Lamy","is_ca":true},{"name":"Wesley Tong","is_ca":true},{"name":"Rajibul Mian","is_ca":true},{"name":"Jessica Vincent","is_ca":true},{"name":"Wojciech Szczeklik","is_ca":false},{"name":"Bruce Biccard","is_ca":false},{"name":"Emmanuelle Duceppe","is_ca":true},{"name":"Maria G. Franzosi","is_ca":false},{"name":"Sadeesh Srinathan","is_ca":true},{"name":"Christian S. Meyhoff","is_ca":false},{"name":"Joel L. Parlow","is_ca":true},{"name":"Denis Xavier","is_ca":false},{"name":"P.J. Devereaux","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00360229940111943,"gpt":0.2121675322841485,"spread":0.2085652328830291,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00151232,0.0001940323,0.002020739,0.000163087,0.00005532619,0.00002591289,0.0001200291,0.00004909311,0.000007478401],"category_scores_gemma":[0.0001988547,0.0001227719,0.003715532,0.0008032839,0.0003999796,0.00009885325,0.00003113376,0.0003173906,0.000003042916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000925718,"about_ca_system_score_gemma":0.000513456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003055454,"about_ca_topic_score_gemma":0.000001118436,"domain_scores_codex":[0.9973113,0.0004864123,0.0007028591,0.0002061711,0.0009805704,0.00031268],"domain_scores_gemma":[0.9972472,0.0007946342,0.0002980668,0.0007172499,0.0007213118,0.0002215459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001080347,0.0001151212,0.7641633,0.00002068882,0.004504282,0.0001667212,0.0002340071,0.00005213735,0.00002172447,0.00002142723,0.000175713,0.2294446],"study_design_scores_gemma":[0.0008509228,0.0001782411,0.9116614,0.0001119468,0.00121112,0.0001197758,0.0004846785,4.38185e-7,0.0003098526,0.000004002014,0.08492587,0.0001417921],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935487,0.003362798,0.000144514,0.001026956,0.0002197918,0.00030346,0.00001870112,0.000005700467,0.00136939],"genre_scores_gemma":[0.9973903,0.00185037,0.0002131433,0.0002373023,0.0002111817,0.00002435328,0.00001005132,0.0000323876,0.00003091306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2293028,"threshold_uncertainty_score":0.5006494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3067367675","doi":"10.1007/s40256-020-00428-8","title":"Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease","year":2020,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Pharmacotherapy; Medicine; Disease; Intensive care medicine; Internal medicine","authors":[{"name":"Charles Pirlet","is_ca":false},{"name":"Paul Poirier","is_ca":true},{"name":"Tomas Cieza","is_ca":false},{"name":"Marie‐Ève Piché","is_ca":false},{"name":"Laurent Biertho","is_ca":false},{"name":"Frédéric Maes","is_ca":false},{"name":"Zoltán Ruzsa","is_ca":false},{"name":"Olivier F. Bertrand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02106993688314508,"gpt":0.3486884589489926,"spread":0.3276185220658476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001586474,0.000743731,0.00939675,0.0004432065,0.00003833067,0.00001058045,0.0004379687,0.0001403683,0.0000448403],"category_scores_gemma":[0.00007439304,0.0004639856,0.01878564,0.0009258818,0.0006156712,0.0001205743,0.00006340766,0.001280767,0.0000155781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005732783,"about_ca_system_score_gemma":0.001990355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005351971,"about_ca_topic_score_gemma":7.507128e-8,"domain_scores_codex":[0.9937441,0.001903418,0.001799007,0.0005811006,0.001507245,0.0004651568],"domain_scores_gemma":[0.9961312,0.0002260899,0.001350419,0.0009595497,0.0004098445,0.0009228619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001494154,0.001040654,0.0287836,0.001409475,0.1342718,0.001452659,0.00009162595,0.0002696821,5.339153e-8,2.958009e-7,0.00005919325,0.8311268],"study_design_scores_gemma":[0.018572,0.005003376,0.04889533,0.01071608,0.1086318,0.0002693578,0.0000202719,0.000005476797,0.00000191616,0.000002432321,0.8072339,0.0006480732],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06216486,0.9361655,0.0001047772,0.00002824511,0.0002193858,0.001221827,0.00005726319,0.0000141444,0.00002405386],"genre_scores_gemma":[0.04617555,0.9527583,0.0002641016,0.0001048067,0.0005119339,0.00002600526,0.00002987146,0.0001246268,0.000004782489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8304787,"threshold_uncertainty_score":0.9997812,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3136802843","doi":"10.1007/s40256-021-00475-9","title":"Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries","year":2021,"lang":"en","type":"letter","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Cross-sectional study; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Anticoagulant therapy; Pharmacotherapy; Environmental health; Virology; Internal medicine; Outbreak; Pathology; Infectious disease (medical specialty)","authors":[{"name":"Inmaculada Hernandez","is_ca":false},{"name":"Mina Tadrous","is_ca":true},{"name":"Jared W. Magnani","is_ca":false},{"name":"Jingchuan Guo","is_ca":false},{"name":"Katie J. Suda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02752992852468971,"gpt":0.3492409598934568,"spread":0.3217110313687671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001974592,0.0005323783,0.003905489,0.0003170794,0.0002126591,0.0001521035,0.0005335577,0.0002970296,0.0001082244],"category_scores_gemma":[0.0003883952,0.0003398981,0.01323949,0.001624466,0.001124802,0.00007757772,0.0001900011,0.001380432,0.000007964072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001747425,"about_ca_system_score_gemma":0.001860576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001911361,"about_ca_topic_score_gemma":0.00001775549,"domain_scores_codex":[0.9938833,0.0006767421,0.001213581,0.0005446462,0.003053926,0.0006278352],"domain_scores_gemma":[0.9954277,0.0002865995,0.001671443,0.00140233,0.0009127232,0.000299167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002304286,0.0002310889,0.7273851,0.0003152769,0.1611204,0.002194354,0.0006139508,0.02515755,0.000003387224,0.000006166527,0.0814637,0.001278566],"study_design_scores_gemma":[0.001665306,0.0007089404,0.724179,0.0002110682,0.01857203,0.002841788,0.0003303253,0.00001097622,0.000004186054,0.00001459822,0.2511435,0.0003182106],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674128,0.006915766,0.001109281,0.02255005,0.0007471831,0.0004599024,0.0006163002,0.0000254949,0.0001631795],"genre_scores_gemma":[0.8792098,0.004956605,0.000075311,0.1130904,0.002387214,0.0000120267,0.0001302471,0.00005853996,0.00007986331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1696798,"threshold_uncertainty_score":0.9999053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W163982164","doi":"10.2165/00129784-200707060-00007","title":"Estimating the Cost Effectiveness of Ramipril used for Specific Clinical Indications","year":2007,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ramipril; Quality-adjusted life year; Life expectancy; Cost effectiveness; Clinical trial; Pharmacoeconomics; Intensive care medicine; Quality of life (healthcare); Internal medicine; Population; Environmental health; Risk analysis (engineering)","authors":[{"name":"Steven A. Grover","is_ca":true},{"name":"Louis Coupal","is_ca":true},{"name":"Ilka Lowensteyn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2098667812940352,"gpt":0.4450840668693218,"spread":0.2352172855752866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1223307,0.0001482834,0.001839225,0.0002983748,0.000161612,0.0000366519,0.0004734843,0.0000690146,0.00001306599],"category_scores_gemma":[0.004391355,0.0001399916,0.001506257,0.0003891191,0.0004380743,0.0002135718,0.00003333664,0.0002848465,0.00003850578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002779623,"about_ca_system_score_gemma":0.0002091494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001066897,"about_ca_topic_score_gemma":0.000001938004,"domain_scores_codex":[0.9932575,0.001148972,0.004768629,0.0002814888,0.0002356947,0.0003077482],"domain_scores_gemma":[0.9856662,0.008120596,0.005063091,0.0006717793,0.0003082231,0.0001701642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001089992,0.00124513,0.3195509,0.001896659,0.02502191,0.00001794887,0.01675258,0.09050342,0.00004990611,0.09099678,0.006506477,0.4463683],"study_design_scores_gemma":[0.01216886,0.001824686,0.6182308,0.001027698,0.0008035267,0.0002247446,0.01396656,0.007629954,0.0003233416,0.01472643,0.3277887,0.001284722],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.3991941,0.003898494,0.5940397,0.00101152,0.0008340863,0.0007074233,0.00004122509,0.000007573175,0.0002657899],"genre_scores_gemma":[0.9742197,0.0001522511,0.024339,0.0004231362,0.0007943145,0.00002726262,0.000005714735,0.00003210305,0.000006534634],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5750256,"threshold_uncertainty_score":0.9037453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4353016809","doi":"10.1007/s40256-023-00576-7","title":"Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Veterans Affairs; Coronary artery disease; Internal medicine; Logistic regression; Odds ratio; Arterial disease; Cardiology; Vascular disease","authors":[{"name":"Salil V. Deo","is_ca":false},{"name":"David McAllister","is_ca":false},{"name":"Sharon LaForest","is_ca":false},{"name":"Salah E. Altarabsheh","is_ca":false},{"name":"Yakov Elgudin","is_ca":false},{"name":"Shannon M. Dunlay","is_ca":false},{"name":"Simerpreet Singh","is_ca":true},{"name":"Sahil A. Parikh","is_ca":false},{"name":"Naveed Sattar","is_ca":false},{"name":"Jill P. Pell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009363041760313886,"gpt":0.2383840948140481,"spread":0.2290210530537342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001666746,0.0003863585,0.001567676,0.0005403166,0.000126964,0.00009404166,0.0002222891,0.00005192677,0.00004435397],"category_scores_gemma":[0.0002485225,0.0002780254,0.002319653,0.001313062,0.0004463288,0.0004454765,0.00005365795,0.0004847276,0.00001139491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002814274,"about_ca_system_score_gemma":0.00100035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001128758,"about_ca_topic_score_gemma":0.00003163392,"domain_scores_codex":[0.9953957,0.0006017943,0.0007798287,0.0004529915,0.002113663,0.0006560601],"domain_scores_gemma":[0.9972441,0.0000755318,0.0003047174,0.001015924,0.000355434,0.001004268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0219749,0.0007911694,0.6743405,0.00173279,0.02044593,0.02257669,0.003624775,0.03869118,0.00005831168,0.00006394558,0.0005081158,0.2151916],"study_design_scores_gemma":[0.00814516,0.0008815666,0.9717757,0.0008217816,0.002743028,0.0004206909,0.001307229,0.0004557022,0.00003143591,0.00002756395,0.01293749,0.0004526982],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942368,0.002336614,0.001532751,0.0006810838,0.0003338629,0.0006938536,0.00002438406,0.00007439712,0.00008621313],"genre_scores_gemma":[0.9958703,0.00180282,0.0003103267,0.0005199025,0.00121736,0.00007788052,0.00004786142,0.00009745642,0.00005607143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2974351,"threshold_uncertainty_score":0.9999672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4307717083","doi":"10.1007/s40256-022-00554-5","title":"Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry","year":2022,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Rivaroxaban; Acute coronary syndrome; Ticagrelor; Aspirin; Internal medicine; Antithrombotic; Cohort; Randomized controlled trial; Clopidogrel; Warfarin; Emergency medicine; Cardiology; Intensive care medicine; Myocardial infarction; Atrial fibrillation","authors":[{"name":"M Millesimo","is_ca":false},{"name":"Edoardo Elia","is_ca":false},{"name":"Giorgio Marengo","is_ca":false},{"name":"Ovidio De Filippo","is_ca":false},{"name":"Sergio Raposeiras‐Roubín","is_ca":false},{"name":"Wojciech Wańha","is_ca":false},{"name":"Emad Abu‐Assi","is_ca":false},{"name":"Tim Kinnaird","is_ca":false},{"name":"Albert Ariza‐Solé","is_ca":false},{"name":"Christoph Liebetrau","is_ca":false},{"name":"Sergio Manzano‐Fernández","is_ca":false},{"name":"Mario Iannaccone","is_ca":false},{"name":"Josè P.S. Henriques","is_ca":false},{"name":"Christian Templin","is_ca":false},{"name":"Stephen B. Wilton","is_ca":true},{"name":"Lazar Velicki","is_ca":false},{"name":"Ioanna Xanthopoulou","is_ca":false},{"name":"Luis Correia","is_ca":false},{"name":"Enrico Cerrato","is_ca":false},{"name":"Andrea Rognoni","is_ca":false},{"name":"Iván J. Núñez‐Gil","is_ca":false},{"name":"Xiantao Song","is_ca":false},{"name":"Tetsuma Kawaji","is_ca":false},{"name":"Giorgio Quadri","is_ca":false},{"name":"Zenon Huczek","is_ca":false},{"name":"Rafael Cobas Paz","is_ca":false},{"name":"José Ramón González‐Juanatey","is_ca":false},{"name":"Shaoping Nie","is_ca":false},{"name":"Masa‐aki Kawashiri","is_ca":false},{"name":"Alberto Domínguez‐Rodríguez","is_ca":false},{"name":"Federico Conrotto","is_ca":false},{"name":"Fabrizio D’Ascenzo","is_ca":false},{"name":"Gaetano Maria De Ferrari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01163399006488068,"gpt":0.2883962855430063,"spread":0.2767622954781256,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003538925,0.0001786476,0.00107046,0.0001185549,0.0001704173,0.00003108887,0.0001873645,0.00002494148,0.00001252845],"category_scores_gemma":[0.0001060581,0.0001048541,0.0006131849,0.0003702438,0.0002969884,0.0001558394,0.0001253733,0.0005038592,3.461741e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001893653,"about_ca_system_score_gemma":0.0001352292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002418054,"about_ca_topic_score_gemma":0.00001596925,"domain_scores_codex":[0.9970314,0.001042931,0.000688427,0.0002736024,0.0007168299,0.0002467954],"domain_scores_gemma":[0.9982872,0.0003876174,0.0006335253,0.0004956788,0.0001317722,0.00006423273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002491174,0.00006293095,0.9739059,0.00005969715,0.002739663,0.00003575063,0.0003846825,0.001318069,2.900281e-7,0.00002021123,0.00002865166,0.01895295],"study_design_scores_gemma":[0.01898935,0.001096616,0.9748266,0.00005828341,0.002101758,0.00005536275,0.001900196,0.0001341299,0.000001504612,0.0001843975,0.0005383508,0.0001133907],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954256,0.001383011,0.0006468451,0.0005681896,0.00008737107,0.001804854,0.00005303276,0.000007362369,0.00002374152],"genre_scores_gemma":[0.9992955,0.0002770966,0.0001951115,0.00007372995,0.00006860199,0.00001760905,0.00003340389,0.00001903096,0.00001995798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01883956,"threshold_uncertainty_score":0.4275825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W19483797","doi":"10.2165/00129784-200303001-00004","title":"A Metabolic Approach to the Management of Ischemic Heart Disease","year":2003,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Disease management; Cardiology; Disease; Internal medicine","authors":[{"name":"Graham Jackson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007764721654874047,"gpt":0.2259966628831594,"spread":0.2182319412282854,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001682526,0.0001915651,0.00104501,0.0002029959,0.00005920077,0.00001484084,0.0001768421,0.00002002928,0.00001543893],"category_scores_gemma":[0.00005939826,0.0001184766,0.003398006,0.000839375,0.000170733,0.00005663237,0.00003698519,0.0002506145,0.000016255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004765123,"about_ca_system_score_gemma":0.0001372225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002752094,"about_ca_topic_score_gemma":3.566039e-8,"domain_scores_codex":[0.9974883,0.0003107156,0.000468096,0.0002211129,0.001262046,0.0002497058],"domain_scores_gemma":[0.9981695,0.00002414716,0.0001827116,0.0009203645,0.000278977,0.0004243094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003313733,0.002285163,0.02443943,0.001137066,0.2183758,0.0006540057,0.006550347,0.05863847,0.0007871748,0.003405573,0.05138848,0.6290247],"study_design_scores_gemma":[0.001419784,0.0001224832,0.02234124,0.00008664915,0.006489613,0.0007137961,0.003540709,0.000008391636,0.000746984,0.000006117814,0.9643748,0.0001494511],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8333769,0.07307436,0.06380171,0.001955618,0.001048466,0.001466117,0.00001159818,0.00004701255,0.02521816],"genre_scores_gemma":[0.9908215,0.001857735,0.005980183,0.0009082506,0.0001937838,0.00001489111,0.000001853149,0.00003483198,0.0001869863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9129863,"threshold_uncertainty_score":0.4831337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}